ð@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ @@@@@@@@@@@@@@@@@@@@@@@@@@ @
―Ž20N(2008N)72ú
ž@RcKG (âÜūģŋÐë)
ķNú@šaQSN(1949N)UQRúC59Î
Z@ Îąæ@ §399-4191·ė§îŠsÔä3230
šaÉėa@
@·
fZ^[·
db0265-82-2121
FAX
0265-82-2317@
e-mail
address@@ s.yamada@sihp.jp
wð
šaSRNRPTú@·ė§ž{[uZēÆ
šaSTNSPú@MBåwãwãwČãwiwÛöüw
1976N/šaTPNRQOú@MBåwãwãwČēÆiãwmæPRVOj
1988N/šaURNRQ8ú@MBåwãwmiģæSTTj
iÆ
1976N/šaTPNTRPú@ãtÆØ
1986N/šaUPNP2QUú@ŽČęåã
1990N/―ŽQNSPú@ú{twïęåã
1990N/―ŽQNSPú@ú{twïwąã
2008N/―ŽQ0NSPú@ú{lÔhbNwïlÔhbNFčã
2001N/―Ž13N71úĐįŧÝÉéŽČęåã
Eð
1976N/šaTPNUPú`šaTQNR31ú@MBåwãwŪa@ãõiĪCãjEŽČ
1977N/šaTQNSPú`šaTRNR31ú@s§b{a@iR§jŽČZpõĻæŅMBåwãwĪķiŽČwuĀj
1978N/šaTRNSPú`šaTTNQP5ú@MBåwãwŪa@ãõEŽČ
1980N/šaTTNQPUú`šaTVNR31ú@ §§Ø]a@ŽČE·ė§ZpõĻæŅMBåwãwĪķiŽČwuĀj
1980N/šaTTNSPú`šaTVNR31ú@ ·ė§Ø]ZqķÅėČņíÎut
1982N/šaTVNSPú`šaTWNR31ú@MBåwãwŪa@ãõEŽČ
1983N/šaTWNSPú`šaUPNX30ú@MBåwãwŪa@ķģŊčEŽČ
1984N/šaTXNSPú`šaUPNR31ú@AJOE National Cancer
Institute, National Institutes of Health, Biological Response Modifiers
Program, Division of Cancer Treatment Ŋw, Visiting Fellow
1986N/šaUPNPOPú`―ŽSNR31ú@·ė§úķAEžãa@ŽČã·ĻæŅMBåwãwĪķiŽČwuĀj. ―ūĩĪķÍ―ŽRNR31úÜÅ
1989N/―ŽģNSPú`―ŽSNR31ú@ ·ė§úķAEžãa@ļČČ·
1991N/―ŽRNSPú`―Ž5NR31ú MBåwãwŽČņíÎiÏújut
1991N/―ŽRNWiTú`PTú n[o[håwEDana-FarberāĪ, Division of Tumor Immunologyj
1992N/―ŽSNSPú`―Ž6NR31ú@ §ž{a@ŽČã·
1992N/―ŽSNPPPú`―Ž6NR31ú@§ž{a@ŪÅėwZut
1994N/―Ž6NSPú`―Ž7NR31ú@ ·ė§úķAExmĐīa@ŽČã·@
1995N/―ŽVNSPú`―Ž18N331ú@ ·ė§ÅėåwEÅė`Ô@\wuĀģö
1995N/―ŽVNSPú`―Ž8N331ú@ ·ė§ÅėåwtŪ}Ų·
1996N/―Ž8N1012ú`―Ž9N331ú@ķČÝOĪõ Cn[o[håwEDana-FarberāĪ, Division of Tumor Immunology Ŋw(n[o[håwãwResearch AssociateCOfficer No. 904-7890-70-60-6) ãĪõC―Ž@ 8N1015ú`―Ž9N330ú)qgÚAÉĻŊéTŨECD26ŠqĖÆuēß@\ÉÖ·éĒ
1998N/―Ž 10N6Pú`―Ž11N331ú@ž{ČåwņíÎutCŽČw
2004N/―Ž 16N`2006N/―Ž18N331úöOqķęåwZÉßZČqķmwČķŧwņíÎut
2006N/―Ž18N43úšaÉėa@
fZ^[fZ^[·
2006N/―Ž 18N7PúšaÉėa@@fZ^[·
2008N/―Ž 20N4PúšaÉėa@@@·
2008N/―Ž 20N4PúMBLėZúåw@ŽÛw@ņíÎut
Ūwï
1976N/šaTPNT`ŧÝÉé@ú{ŽČwïCú{ŽČwïbMnûï@@@@@@@@@@@@@@@@@@@@@@@@@
1978N/šaTRNS`ŧÝÉé@ú{twïiïõÔ13005j
1980N/šaTTNS`ŧÝÉé@ú{Æuwï(ïõÔ545-525-3272)
1995N/―Ž7NS`ŧÝÉé@}Nt@[WŠqŨEķĻwĪï
2006N/―Ž18NS`ŧÝÉé@ú{lÔhbNwïiïõÔA-5116j
Üą
Ü/1985N/šaUONQ`šaUPNR Visiting Fellow §wāiFogarty International Center,@§qķĪE§āĪj
1986N/šaUPNPQ Biological Response
Modifiers Program Award, NCI, NIH
ą/Čĩ
I
1.ÔHūYCRcKG: Ža.@Žãw14(1) : 14 - 40, 1981.Ī 1981.1.@(ša56N 1) Žãw 14Š1p.14`p.40@ aĄÃĖŠēÍCÆuÄ@\ĐįÆęÄBðąŊÄĒéaŨEN|ðÁÅģđéąÆÅ éDŽ}ŦaĖķķĶÍCffCĄÃĖi⯯āÉĩüãĩ―DąęÍCaöCaÔĖĪĖiāCVĩĒff@ĖąüC\ãvöÉîÃ―ÜđpŧwÃ@ĻæŅÛÃ@ĖüPC_onđĮĖ\hÉæé
2.RcKGC{ėKš@: T ŨEĖŠŧÆŽÉĻŊé@\B.@Žãw@20(3) : 381 - 402, 1987.
(ša62N 3) 20Š3.T ŨEÍRīðT ŨERīZv^[ÅFŊ·éŠCąĖÆŦåvgDKRīĄĖĖFŊāKvÆ·éDT ŨEĖŠŧÍđBāÅNąčCģÜīÜČT ŨE@\ðlūĩÄĒDŽúÉĻŊéT ŨECB
ŨECP
CPHA, RCD3RĖÉηé―ŦÍģíÅ éŠCPWMĖB ŨEÉæéÆuOuYķÉÎĩÄCVķCD4+T ŨEÍ}§IÉDÜ―TŨEĖinterferonYķŠášĩÄĒéD
3.Ž{R~CkīķŋCsėģîCRcKGCėC{ėKš C]ûõŧC
JCICÔHūY: Natural killer ŦðL·éŽĖ}ŦpŦa.@ ÄcšCvjŌ.@aĖVĩĒffZp.@æ 4 ņVV|WE.pp.74-81, ãōoÅŪïÐ.@ 1988.Ī1988.12.(ša63N12).@aĖVĩĒffZpCæ4ņVV|WE@p.74`p.81 ãōoÅC}ŦpŦa(ALL)ÍĒnČîáŨEÅ čCģíĖp
@\ðŧ·éąÆÍÜęÅ éDĄņALLŨEŠCnatural killer(NK)ŨEŦð
L·éęŠ éąÆðĐoĩ―DALLŨEÍCE-[bgð`Žĩ―ŠCK562îáŨEÉÎĩÄŨEáQŦðĶĩCNKŨEnņĖŨEÆlĶįę―D
4. RcKG(ŠS·M)FĀKÉð§ÂaÔ}bv@üų2Å
`Ô@\}bv1.ÁŧĮ6-9
`Ô@\}bv2.Ė26-29
`Ô@\}bv3.S50-53
`Ô@\}bv4.Äzí76-79
`Ô@\}bv5.]EŌ92-95
`Ô@\}bv6. EÖßE―_o116-119
`Ô@\}bv7.t136-139
`Ô@\}bv8.ŦķBíPTU—PTX
`Ô@\}bv9.āŠån172-175
`Ô@\}bv10.GlM[ķŽEēß@\180-183
`Ô@\}bv11.Æu@\188-191
`Ô@\}bv12.tEĒí196-199
`Ô@\}bv13.ÚEĻ212-213
`Ô@\}bv14.į222-223
`Ô@\}bv15.AM[228-229
aJthÐ 2005N415ú
4a. RcKG(·M)FĀKT|[gJ[hAĀKÉð§ÂðU}W
i[VOJbW@2005N4@ãw|pÐ@
http://www.igpc.co.jp/
5. RcKG@Ō@ÅėĖ―ßĖaÔnhubN@775y[W@ãw|pÐ@ISBN4-87054-260-9 čŋ4600~+Å(4830~)@2005N1210úæ1Åæ1ü
http://www.igpc.co.jp/
6. RcKG@ŠS·M:îbItBWJAZXgZpĖĀÛAîbŠíĐéI ĀHÅŦéItBWJAZXg, ūcģŌWp10-p64, ISBN
4-7965-1421-XÆŅÐ,A―Ž18N(2006N)6 čŋ2100~
7.RcKG(ÄC)FūģĘÅėßöZ~i[[üųÅ]Bãw|pÐ@ISBN4-87054-277-3 čŋ4800~+Å(5040~)@2006N125ú æ1Åæ1ü
æ1ÍÄzíp10-p15
æ2ÍzÂíp116-p121
æ3ÍÁŧíp240-p245
æ4Ít•åAíp364-p368
æ5Í]Į•_o•Øp428-p436
æ6Í^Ūí•t•h{•ãÓp554-p561
æ7Íīoí•Æu•_op644-p647
æ8ÍŦķBíp728-p729
http://www.igpc.co.jp/
8.RcKG@F@·ĒÄ•ĮņÅðISđAÄzđARgRtđ(ģŠč)@v`i[X@ÆŅÐAA16(7):18-37,
2007N6
9.RcKG@Ō@ÅėĖ―ßĖaÔnhubNüųÅ@813y[W@ãw|pÐ@ISBN978-4-87054-296-9
čŋ4600~+Å(4830~)@2007N910ú@æ2Åæ1ü
http://www.igpc.co.jp/
10. žjĄ,RcKG@Īó:uAbbas AK, Lichtman AH:Basic
Immunology Elsevier Saunders 2nd ed.2006-2007 updated editionvuîbÆuwFÆuVXeĖ@\ÆŧĖŲí@īæ2Å@2006-2007ÅVÅv,@G[rAEWp,2007.12.25@æ1Åæ1üs@čŋ5800x1.05=6090~ISBN978-4-86034-869-4
http://www.elsevierjapan.com/
10aRcKG@}ÏĶIðUķaÔnhubN@ãi[XZ~i[ÁĘŌWp1-45AúĪoÅ2008.6
11. žjĄ,RcKG@Äó@:uAbbas AK, Lichtman
AH:Cellular and Molecular Immunology, 5thed 2005 Elsevier Saunders vuŠqŨEÆuw@īæ5ÅvG[rAEWp,2008.7.15@čŋ9800x1.05=10290~
http://www.elsevierjapan.com/
IIwp_ķ @@@
@@@@@@@@@@@@@@@@@@@@@
1.Miyagawa,
Y., Yamada, S., Komiyama, A., and Akabane, T.: Measurement of
Donath-Landsteiner antibody-producing cells in idiopathic nonsyphilitic
paroxymal cold-hemoglobinuria in children. Blood 52(1):97-101, 1978.Ī 1978.1.(ša53N 1)@Blood 52 Š1p.97`p.101@@ ÁŦņ~ÅŦėŦĶâFfAĮ(PCH)Ė2Îðoąĩ―DDonath-Landsteiner(DL)RĖYķŨEðplaque-forming
cell(PFC)Šč@ÉÄĒĩ―D}ŦúÉÍPFCŠzŦÅ čCDLRĖŋālðĶĩ―D°ðúÉÍPFCCDLÆāášĩ―DPCHĖffÉPFCŠč@ŠLøÅ Á―D@
2.īqCRcKGCâäšFCęōÛVCXNvCVėęYCgcõmC|āT: Albrights' hereditary osteodystrophy. á Ca ĮðLĩCPTH ŨÉæčA P ãļCc-AMP á―ðĶĩ― 1 Žá. ãÓ@11(1) : 162 - 170, 1978.Ī 1978.1.(ša53N 1)@ãÓ11Š1p.162`p.170.@13ÎĖDp\ŠßŠåÅ éÉāĐĐíįļCáCaĮCPĮĖbóB@\ášĖĐðæĩCģįÉZëC~`įeCZwæäĮCŲŦÎDŧĖAlbrights' hereditary osteodystrophyĖĐðæĩÄĒ―DPTHŨÉæčAPã
ļCc-AMPá―ðĶĩ―D
3.RcKGCÂRėCâgļCRč@LCŽręCÐRaMCÔHūYCŠėÆCxÛ: Vķ}XXN[jOÉæčĐoģę―qX`WĮSáĖÕ°IÏ@. MBã@27(3) : 299-303, 1979MBã27Š3p.299`p.303 Vķ}XXN[jOÉæčĐoģę―qX`WĮģÉCáqX`WēûðpĒĄÃĩ―DqX`WZxð3-5mg/dlÉÛ·éĖÉ33mg/kg/dayĖqX`WÛæŠKvÅ Á―Dļ_^ŪBxŠFßįęļCĮDČoßðÆÁ―D
4.RcKGCËcđ CŽ{R~CÔHūYCvÛbkCåvÛMęCÔđOCÛRYĒ : pOffģę―ŽxŠæĮĖPá.@ŽČÕ°@32(11) : 2273 - 2277, 1979. 4ÎĖD―·éMCPðåiÉófĩ―DķšxėÉđŠŪĐęCđX-PÅÍķšxėÉXEŦ˧šŠĐįę―D åŪŽĒeÉÄ oŪŽĐįŠōĩãsĩÄCķšxĖXEÉüéŲíŪŽŠFßįę―D1979.11.ša54N11.ŽČÕ°32Š11p.2273`p.2277.
5.šÝēCuc°CRcKG: ŽxŠæĮĖPčpá.@MBã@28(1) :144 - 148, 1980.Ī1980.1.(ša55N 1) @@ MBã
28Š1p.144`p.148.@4ÎĖDxŠæĮĖXEÍĐFðŅŅCģíxÆÍūÄÉæŠģęCåŽĖXEóîáŠęōÆČÁÄęÂĖXEð`ėéOÏðÆÁÄĒ―DŲíŪŽÍxÔÉÁÄãsĩÄĒ―DģíxÆĖŦEÍü
ŠCĢŠĒïÅ čCķšxtØðsÁ―DčpãĖoßÍēÅ Á―D
6.āĄĢCRcKGC|āTCÔHūYCXNv,@gcõmCVėęY.@TRHÃ@ÉæčŽ]ļēĮóĖüPðÝ― Kockayne ĮóQĖPá.@zÆÕ° 30(3) : 261 - 266,
1982.@Ī1982.3.(ša57N3)zÆÕ°Š3@p.261`p.266. 13ÎjDŽlĮCVllįeCUíC^ŪļēCm\áQðšĪKockayneĮóQÉÎĩÄCthyrotropin releasing
hormone(TRH)ð^ĩ―ÆąëCĮóĖüPŠĐįę―DTRH^ÉæčCT3,T4,TSHĖÏŧÍFßįęļCŧĖėpÍ]ÖĖžÚėpÉæéāĖÆlĶįę―D
7.Yamada,
S., Miyagawa, Y., Komiyama, A., and Akabane, T.: Further immunologic
characteristics of pre-B-cell acute lymphoblastic leukemia in children. Acta
Haematol. Jpn. 46(1):141-146, 1983.Ī1983.1. (ša58N 1)@Acta@Haematol.@Jpn.@46Š1p.141`p.146.@Pre-BŨE^Ž}ŦpŦa(ALL)ðoąĩ―DPre-BŨE^ALLŨEÍCŨEŋāÉIgMðÛLĩÄĻčC}EXÔ
Æ[bg`Žðĩ―ŠCasialo
GM1ÍAŦÅ Á―DÕ°IÉÍNÉÝįęnCĖäBîŠC
Ė―ŠFßįę―
8.ãīĮYCRcKG, ėÎKCžtŠvC{ėKš : Single cell
mediated cytolysis @ÉæéNatural killer yŅInterleukin 2-induced natural killer - like cells ĖŨEĖŠč. 1. îbIĒ. Õ°Æu 15(3) : 228 - 235, 1983. Ī1983.3.(ša58N 3)Õ°Æu 15Š3p.228`p.235@@@@@@ Natural killer(NK)ŨEŦðŠč·éû@Æĩ
ÄC°ũūðpĒÄŠčÂ\ČSingle
cell mediated@cytolysis@ðpĒ―DRIðpĒ―û@ÆĮÖĩ―DNKŨEÍOKM1zŦÅ Á―DInterleukin 2-induced
NK-like cellÍOKM1AŦÆČčCOKT3zŦŨEĖŠÁĩ―
9.ҰFC―ŅLęCRcKGCËcNCåÔxvCŽ{R~CÔHūY :Natural killer ŨEŦᚊFßįę―}ŦdŧŦS]ĖPá.@ŽČfÃ@ 46(3) : 417 - 420, 1983.Ī1983.3. (ša58N 3)@@ ŽČfà 46Š3p.417`p.420@@@@ @}ŦdŧŦS] (SSPE) ÍC]ECXīõãÉøŦNąģęé\ãsĮĖ]ÅCxŦECXīõĮÅ éD7ÎjqDSSPEÉëģĩCnatural killer (NK) ŨEŦᚊFßįę―DTransfer
factor(TF)ðpĒÄĄÃĩ―DTF^ÉæčNKŨEŦŠãļĩCĮóÍęIÉüPĩ―D
@
10.Ž{R~CRcKG: ĖĖÆu.@ŽÅė@67(10) : 1312 -1320,
1983.Ī 1983.10.ša58N10 ŽÅė 67Š10p.1312`p.1320. ĖĖĮCŦŧÉĻŊéŨEáQėpC·ČíŋĖŨEjóÉÍCp
CÁÉŨEáQŦTp
ŠÖ^ĩÄĒéDB^ĖÉĻŊéĖŨEáQ ÍCB^ĖEBXÖARī(HBsRī)Éæčīėģę―Tp
ŠĖŨEãĖWIRīÆ―ĩCīėĖŨEðÏŦóÖÆąD
11. ÔHūYCRcKG : Non-Hodgkin pîĖÕ°Æa. T1 cell
malignancy.@ ú{Õ° 41(11) : 2555 - 2560,
1983.Ī 1983.11.(ša58N11)@ú{Õ° 41Š11p.2555`p.2560 Non-HodgkinpîÉÍCTŨEnîአčCđüp
^ðT1^ÆÄņÅĒéDT1^ÍåÆĩÄŽÉFßįęCĒŠŧČTŨEĐįRĩÄĒéDîáŨEÍE[bgð`ŽĩCTŨERĖÉ―ĩCđüŨERÆlĶįęéDĄÃÍT
cell@ALLÆŊlÉÍČŧwÃ@ðsĪKvŠ é
12.ÔHūYC@RcKG@: Hereditary
Elliptocytosis.@ŽāČ@15iÕ§j : 317 - 318, 1983.Ī@1983.12.ša58N12 ŽāČ 15Šp.317`p.318 @Hereditary
elliptocytosisÍC―É―ĖČ~Ô
Šoŧ·éâ`ŦnŦūģÅ éDÔ
ĖãÓŲíŠīöÅ éDnÍãģęÄĒé―ßCnÍFßįęČĒąÆŠ―ĒDnаÆČęÎĐátðķļéąÆŠ éDnŦnáÅÍäBîĖķÝ·éąÆŠ―ĒDnĮóÍEäBÉæčüP·éD
13.Yamada,
S., Miyagawa, Y., Komiyama, A. and Akabane, T.: Expression of glycolipids on
target cells susceptible to human natural killer cell-mediated cytolysis. Acta
Haematol. Jpn. 47(1):41-47, 1984. 1984.1. (ša59N1)@Acta Haematol.Jpn.@47Š1p.41`p.47@ qgnatural killer (NK) ŨEīóŦWIŨEĖŨE\ĘŋðĒĩ―DK562WIŨEÍCasialo GM1Casialo GM2CglobosideCparaglobosideCForssmanðLĩÄĒ―DRasialo GM1RĖCRgloboside RĖuÉæčŨEáQŦÍášĩ―DNKŨEÍasialo
GM1CglobosideðWIŨE\ĒÆĩÄFŊĩÄĒ―D
14.
Yamada, S., Miyagawa, Y., Komiyama, A., and Akabane, T.: Analysis of natural
killer cell defects in childhood acute lymphoblastic leukemia.@ Jpn. J. Clin. Oncol. 14(1):75-80, 1984.@ Ī 1984.1. (ša59N 1)@@ Jpn. J. Clin.@Oncol.14Š1p.75`p.80 Natural killer (NK) ŨEÍCRîáėpðL·ép
Å éDŪS°ðĖŽ}ŦpŦa(ALL)ģĖNK ŨEŦÍCĄÃĻæŅĄÃIđãāášĩÄĒ―DLeu 7zŦŨEÍCĄÃÍášĩÄĒ―ŠCĄÃIđãÍģíŧĩ―DALLģÉĻŊéNKŨEĖŋIŲíŠĶīģę―D
15.Komiyama,
A., Yamada, S., Kawai, H., Miyagawa, Y., and Akabane T.: Childhood acute
lymphoblastic leukemia with natural killer activity: Clinical and cellular
features of three cases. Cancer 54(8):1547-1553, 1984. Ī 1984.8.(ša59N 8)@Cancer54Š8p.1547`p.1553 K562ŨECMolt3ŨEÉÎĩÄCnatural killer (NK)ŨEŦðĶ·Ž}ŦpŦa(ALL)ŨEðoąĩ―DąęįaŨEÍEZv^|CIgGFcCOKM1ŠzŦÅ Á―DđBîåĖFßįęČĐÁ―ĮáÍCNKŨENđÅ Á―DTŨENđĖĮáāFßįę―D
16.âgļCRcKGCŽ{R~CÔHūY :Ž}ŦaĖÓúáQÆĩÄĖ NK ŨEŦĖĒ. Žā 20:95-97, 1984.Ī 1984.12.(ša59N12)@Žā 20Šp.95`p.97 Natural killer (NK) ŨEÍCîáÆuÉĻĒÄdvČŦðĩÄĒéDNK ŨEŦÍCŽ}ŦaĖĄÃĖÝČįļCoff-therapyãÉāášĩÄĻčCNK ŨEĖ@\ŲíŠķÝĩ―DInterferonCinterleukin 2Éηé―ŦāášĩÄĻčCNKŨEĖÓúáQÆĩÄŋIŲíŠFßįę―
17.Komiyama,
A., Kawai, H., Yamada, S., Aoyama, K., Yamazaki, M., Saitoh, H., Miyagawa, Y.,
Akabane, T., and Uehara, Y.: Impaired natural killer cell recycling@in childhood chronic
neutropenia with morphological@@ abnormalities@ and @defective chemotaxis of neutrophils. Blood 66(1):99- 105, 1985.Ī@@@@@@ 1985.1.(ša60N 1)@Blood 66Š1p.99`p.105. ŽŦD
ļĮģĖęÉnatural
killer(NK)ŨEŦŠášĩÄĒ―DNKŨEŦÍCinterferonCinterleukin 2É―ĩ―ŠCģíÜÅÍ―ĩČĐÁ―DNKŨEŦĖášĖīöÍCrecycling\ÍĖášÉīöĩÄĒ―D
18.îėGĀCÁĄģYCÎļCÎähOYCÂRėCâgļCėCĢļCRcKGCĻīrC{ėKš@Ëcđ @ÔHūYCû^V : Ž
ALL @ÉŊnÚAÆÚAãÛÃ@ðsČÁ―Pá.@Õ°t@26(3) : 455 -460, 1985.Ī 1985.3.(ša60N 3)Õ°t 26Š3p.455`p.460.@5ÎD}ŦpŦaĖÄÉÎĩCęŦoķĐįŊnÚAĀŅÉÄ\hĖ―ßĖÚAãÛÃ@ðsĒCđĮČŪSŪððÛĩÄĒ―D
19.Yamada,
S., Yanagisawa, M., Miyagawa, Y., Komiyama, A., and Akabane, T.: Prompt
reconstitution of natural killer cells after bone marrow transplantation. Acta
Haematol. Jpn. 48(6):1451-1458, 1985.Ī1985.6.@(ša60N 6)@Acta Haematol.@Jpn.48Š6p.1451`p.1458. ŽÄķsĮŦnCŽ}ŦpŦaģÉÚAðsÁ―DÚAãPČāÉCnatural@killer(NK)ŨECNKŨEŦÍņĩ―ŠCTŨECBŨEĖŦÍņĩČĐÁ―DNKŨEĖ}ŽČņÍCÚAĖķ
ð\Šĩ―D
20.RcKGC{ėKš. TŨEĖŠŧÆŽÉĻŊé@\BDĪ1987.3.(ša62N3)@Žãw20Š3p.381`p.402.@ TŨEÍRīðTŨERīZv^|ÅFŊ·éŠCąĖÆŦåvgDKRīĄĖĖFŊāKvÆ·éDTŨEĖŠŧÍđBāÅNąčCģÜīÜČTŨE@\ðlūĩÄĒDŽúÉĻŊéTŨECBŨECP
CPHACRCD3RĖÉηé―ŦÍģíÅ éŠCPWMĖBŨEÉæéÆuOuYķÉÎĩÄCVķCD4+TŨEÍ}§IÉDÜ―TŨEĖinterferonYķŠášĩÄĒéD
21.Yamada,
S., Ruscetti, F.W., Overton, W.R., Herberman, R.B., Birchenall-Sparks, M.C.,
and Ortaldo, J.R.: Regulation of human large granular@lymphocyte and T cell growth
and function by recombinant interleukin 2: Induction of interleukin 2 receptor
and promotion of growth of cells with enhanced cytotoxicity. J. Leuk. Biol.
41(6):505-517, 1987.Ī @@@@@@ 1987.6. (ša62N 6)@J. Leuk. Biol.41Š6p.505`p.517 Natural killerŦðSĪqgåčũąp
(LGL)ĖK562ŨEÉηéŨEáQŦÍCinterleukin2(IL2)ÉËķĩ―DIL2ÍVNLGLÉ]ĘxÅIL2Zv^[ðUąĩCLGLĖBðĢiģđCŨEáQŦðģđ―DIL2ÍÃ~LGLĖBðUąĩCÍČŨEáQŦðL·éLGLĖBðÛ·éĖÉKvĐÂ\ŠÅ Á―D
22.Yamada,
S., and Ortaldo, J.R.: Regulation of human large granular lymphocyte and T cell
growth and function by recombinant interleukin 2:@Acquisition of potent cytotoxic capabilities. J.
Leuk. Biol. 42(3):263-272, 1987.Ī 1987.3.(ša62N 3)@@@ J. Leuk. Biol.42Š3p.263`p.272 @Natural killerŦðSĪqgåčũąp
(LGL)ÆTŨEðPercollädū@ÉæčŠĢĩ―DInterleukin 2(IL 2)Éæč|{ģę―LGLÍCVNLGLæčāK562ŨEÉηéŨEáQŦÍĐÁ―DIL 2|{TŨEāK562ŨEÉηéŨEáQŦðlūĩ―ŠCIL 2|{LGLæčāŨEáQŦÍãĐÁ―DIL 2|{LGLCTŨEÍCVNLGLæčāK5623EÉηéĒ\ðlūĩ―D
24.Komiyama,
A, Kawai, H., Yamada, S., Kato, M., Yanagisawa, M., Miyagawa, Y.,Akabane, T.: A
killing defect of natural killer cells with the absence of natural killer
cytotoxic factors in a child with Hodgkin's@disease. Blood 69(6):1686-1690, 1987.Ī1987.6. (ša62N 6)Blood69Š6p.1686`p.1690.ŽzWLaģÉĻĒÄnatural killer
cytotoxic factor(NKCF)ŠđĩÄĒ――ßCnatural killer(NK)ŨEŦŠášĩÄĒ―Įáðoąĩ―D Leu 7CLeu11ŨEÍģíÉķÝĩ―D`ÔwIÉālarge granular lymphocyteÍķÝĩ―DK562ŨEhÉæčNKCFðYķĩČĐÁ―D
@
25.RcKG : IL 2 Éæéqg NK ŦĖ.@Medical Immunology 15(3) :
353- 360, 1988. (ša63N 3)15Š3Zxinterleukin 2(IL 2)ÍCnatural killer(NK)ŨE(Large granular lymphocyte)ĖBðUąĩ―DIL 2ËķŦÉBĩÄĒéLGLÍCÍČŨEáQŦðlūĩ―DąĖŨEáQŦÍCIL
2ËķŦÉBĩÄĒéTŨEĖŨEáQŦÆäŨĩÍÅ Á―DIL 2ËķŦÉBĩÄĒéLGLðpĒ―adoptive transfer therapyŠÂ\Å éD
@
26.Komiyama,
A., Ishiguro, A., Kubo, T., Matsuoka, T., Yasukohchi, S.,Yasui, K., Yanagisawa,
M., Yamada, S., Yamazaki, M., Akabane, T.:Increases in neutrophil counts by
purified human urinary colony-stimulating factor in chronic neutropenia of
childhood. Blood 71(1):41-45, 1988.@@ Ī1988.1.(ša63N1) Blood 71Š1 p.41`p.45@ŽŦD
ļĮģÉĻĒÄCŧqgA colony
stimulating factor(CSF)ð^ĩ―ÆąëCD
ĖÁŠFßįę―DCSFÍCĖD
OėŨEÉąÆŠčģę―D
27.RcKG.IL 2ÉæéqgNKŦĖD P1988.3.(ša63N 3)Mcdical Immunology15Š3p.353`p.360 Zxinterleukin 2(IL 2)ÍCnatural killer(NK)ŨE(Large@granular lymphocyte)ĖBðUąĩ―DIL 2ËķŦÉBĩÄĒéLGLÍCÍČŨEáQŦðlūĩ―DąĖŨEáQŦÍCIL
2ËķŦÉBĩÄĒéTŨEĖŨEáQŦÆäŨĩÍÅ Á―DIL 2ËķŦÉBĩÄĒéLGLðpĒ―adoptivetransfer therapyŠÂ\Å éD
28.RcKGC{ėKš : T ŨEZv^[đĮ.@ú{Õ°ÆuwïG@21(1): 22 - 33,
1989.Ī 1989.1.(―ŽģN 1)@ú{Õ°ÆuwïG 21Š1p.22`p.33@@ TŨEÍCTŨEZv^|(Ti)ÉæčRīCåvgDKRīĄĖðŊÉFŊ·éDTŨE@\ŠqĖŧÍCđBãįŨECãįŨEĐįŠåģęétŦöqCinterleukin 2ĖcytokineÉæčC·ŨÄđüũŨÂŦāÅNŦéDTŨEÍCD3/TiðîĩÄîņ`BðsĪDTiŠđ·éÆTŨEÆusSĮŠĮ·éD
29.Yamada
S, Miyagawa Y and Komiyama A.: Decreased cytotoxic potential of fresh and
recombinant interleukin 2-cultured large granular lymphocytes in childhood
acute lymphoblastic leukemia. Leukemia Res., 15(5):367-372, 1991.Ī1991.5. (―Ž 3N 5) Leukemia 15Š5 p.367`p.372 ĄÃĖŽ}ŦpŦa(ALL)ģÉĻŊéVN éĒÍinterleukin 2(IL
2)|{åčũąp
(LGL)ĖŨEáQŦøĶÍášĩÄĒ―ŠCLGLĖ\ÍCášĩÄĒČĐÁ―DLGLĖŨEáQŦ\ÍCĄÃĖALLģÉĻĒÄ\ĖášÅÍČCãĖŨEáQßöÉĻŊé@\ášÉæčIðIÉášĩÄĒ―D
30.Yamada,
S., Kawai H, Miyagawa, Y. and Komiyama, A. : Effect of radiotherapy on natural
killer activity in childhood acute lymphoblastic leukemia and malignant
lymphoma. Leukemia and Lymphoma, 4:343-349, 1991.Ī1991.8.(―Ž 3N 8)Leukemia and Lymphoma.4 Š@ p.343`p.349Ž}ŦpŦa(ALL)ģÉĻĒÄC\hIŠWúËüÆËðsĪÆCnatural killer(NK)ŨEŦŠÁĩ―ŠCNKŨEÉÍÏŧÍČĐÁ―DŦŦpîģÉĻĒÄCčōpßúËüĄÃðsÁÄāCNKŨEŦCNKŨEĖļÍČĐÁ―DúËüÍCžÚÉNKŨEÉĒÄĒéąÆŠčģę―D
31.Yamada
S and Komiyama A. : Decrease in number of CD16(Leu 11) +CD45RA(2H4)+ cells and
defective production of natural killer cytotoxic factor in childhood acute
lymphoblastic leukemia. Leukemia@Res., 15(9):785-790,1991. Ī 1991.9. (―Ž 3N 9)@Leukemia Res.15Š9p.785`p.790@ CD16CCD45RAÍCnatural killer(NK)ŨEÉĻĒÄŦŧVOið^ĶÄĒéDŽ}ŦpŦa(ALL)ģÉĻĒÄCD16(Leu11)ECD45RA@(2H4)zŦŨEŠášĩÄĻčCnatural killer@cytotoxic factor (NKCF)ĖYķŠášĩÄĒ―DALLģÉĻŊéNKŨEŦášĖęöÆĩÄCNKCFYķĖᚊčģę―D
32.Yamada
S, Ichikawa M and Komiyama A. : Impaired cytotoxic activity of
interleukin
2 (IL 2)-cultured large granular lymphocytes (LGL) in@childhood acute lymphoblastic
leukemia. Quantitative measurement of IL 2 receptor expression of IL 2-cultured
LGL. Leukemia and Lymphoma,@ 6:65-73,
1991.Ī1991.11.(―Ž 3N11)@ Leukemia and@Lymphoma.6 Š p.65`p.73@@@@@@ @Ž}ŦpŦa(ALL)ģÉĻĒÄCinterleukin 2(IL 2)|{åčũąp
(LGL)ĖŨEPÂ―čĖIL2 receptor(IL2R, CD25)ÍášĩÄĒČĐÁ―DIL 2|{LGLĖŨEPÂ―čĖeaŦIL 2RÍģíÅ čCąęįŨEĖeaŦZv^[eaŦÍášĩÄĒ―DIL 2ÆIL2RĖs\ŠČÝėpŠąęįŨEĖŨEáQŦĖášĖęöÆČÁÄĒ―D
33.RcKG : ä`oĖFßįę―VķÉηér^~ K Ė^.@ ŽČfÃ55(8):1682-1686, 1992.P 1992.4.(―Ž 4N 8 )ŽČfÃ55Š8p.1682`p.1686 VķEûr^~jRŦoĮÆvíęéä`oĖFßįę―ģÉÎĩÖpvX`eXgð{sĩCr^~joû^ðsÁ―Dr^~j\h^ðsÁ―VķĖęÉä`oŠFßįę―Dä`oÍÖpvX`eXglŠ46öxÅoŧ ĩCr^~j^ÉæčÖpvX`eXglŠãļĩĄüĩ―ąÆÉæčCr^~j^ÉæéĄÃÍLøÆvíę―D
34.RcKG : ŽúoZhEaÉĻŊé TSH Zv^[RĖ (TRAb)CbóBh
RĖ (TSAb) ČĮĖĐČRĖĖÚĖĒ. ŽČÕ° 45(11):2460-2464,@1992.P@ 1992.11.(―Ž 4N11)ŽČÕ° 45Š11p.2460`p.2464 ŽúoZhEaÉĻĒÄvs`IEVÉæéĄÃðsĒCbóBĐČRĖĖÚðĒĩ―DĄÃÉæčT3CT4ŠģíÍÍÉ čČŠįCTSHZv^[RĖÍãļĩ―ãCálðĶĩ―DbóBhRĖāálðĶĩ―DRTCOuRĖCR}CN][RĖÍCĄÃðąŊÄĒÄāAŦŧđļÁĩ―DĐČRĖĖYķÍĘXÉēŪģęÄĒ―D
35.RcKG :]ģÉĻŊé Lactate dehydrogenase
(LDH) AC\UCÉÖ·éĒ. ŽČ
33(11):1519-1522, 1992.@P1992.10.(―Ž 4N10) ŽČ33Š11 p.1519`p.1522 ]]úģĖ―p
ÍļĩCīLactatedehydrogenase
(LDH) lÍÁĩÄĒ―DLDHAC\UCl 1]5 ^ÍŧęžęÁĩÄĻčCÁÉLDH3^ĖŠÁĩÄĒ―DīGOTlāÁĩÄĻčCLDH^G0TäÍ18i0]5ÎjĻæŅ15i6]15ÎjÅ Á―DīLDHlĖÁÍC]ECXīõÉæčŦŧģę―p
RÆlĶįę―D
36.RcKG :šĖŦŽlĮÉĻŊ鎷zgpĖNîĖ]ŋ@ĖĒ. ŽČÕ° 45(11):2483-2488, 1992. P1992.11.(―Ž 4N11)ŽČÕ°45Š11p.2483`p.2488@šĖŦŽlĮĖĄÃÉŽ·zðgpĩCNîĖ]ŋðsÁ―DŽ·zgpOÉNîĖĩĒxęŠ Á―ŠCŽ·zgpÉæčg·ŠLŅCNîāïNîĖLŅÆŲÚŊlČLŅðĶĩ―DTanner]Whitehouse 2iTW2j@ĖûŠCGreulich]PyleiGPj@æčNîĖüPŠFßįę―DŽ·zgpĖNîĖ]ŋ@ÍTW2@ĖûŠDęÄĒéÆvíę―D
37.RcKG :Epstein-Barr ECXRĖŋĖNîĘÚÆŽ`õŦPjĮĖĮNîĖĒ.
ŽČ
34(4):353-357, 1993.P1993.4.(―Ž 5N4)@ŽČ 34Š4p.353`p.357@ÅßĖ5NÔÅ4áĖ`õŦPjĮģŠÏ@ģę―D7ĐĐį4Î11ĐC―Ï2Î8ĐÅ Á―DNÎÆŽÉĻŊéEB VCA]IgGRĖyŅEBNARĖÛLĶÍŧęžę5ÎČãÅ80%ČãÆČčC12ÎČãÅÍ100ÆČÁ―D{MÉĻŊé`õŦPjĮÍCûcúÉĶÉEBEBXĖīõŠNąčĮ·éąÆŠ―ĒÆvíę―D
38.RcKG :Ž`õŦPjĮÉĻŊéLactate
dehydrogenase (LDH) AC\UCÉÖ·éĒ. ŽČÕ° 46(6):1307-1310, 1993. P1993.6.(―Ž5N6)@ŽČÕ°46Š6p.1307`p.1310@}Ŧú`õŦPjĮģĖīLDHĻæŅLDHAC\UCðĒĩ―D`õŦPjĮģĖ―p
ŠÁĩÄĻčCīLDHlÍãļĩÄĒ―DLDHAC\UClÅÍLDH3^ĖŠÁĩÄĒ―DīLDHlÆp
ÆĖÖWÍ0.61Å Á―DīGOTlāÁĩÄĻčCLDH^GOTäÍl4Å Á―D`õŦPjĮÉĻŊéLDHĖãļÍCp
ÉRĩ―D
39.RcKG : Transient stem cell
proliferation, megakaryo-oriented lineageðđĩ―_EĮóQĖ1á. ãà 48(4):305-310, 1994.P@1994.4.(―Ž 6N4)@ãÃ48Š4p.305`p.310@Transient stem cel1
proliferationCmegakaryo-oriented@ lineageðđĩ―_EĮóQĖláðoąĩ―D―
Í72,870^mm3Å čCč
Š37ðčßÄĒ―DŽÂÍ57.2^mm3ÆÁĩÄĒ―DCD34ĻæŅCD7Í―CÅÁĩÄĒ―DÜ―CCD41ā―CÅÁĩÄĒ―Dč
ÍCmegakaryo]oriented 1ineageĖstem cellÆlĶįę―D
40.RcKG : ŽAM[ŦÁaÉĻŊétÃÅæXIIIöqŦÆÁaŦtÆĖÖA. ŽČÕ° 49(1):39-42, 1996@@@@@@@ P1996.1.(―Ž 8N1)@ŽČÕ°49Š1p.39`p.42@ŽAM[ŦÁaÉĻŊéÁaŦtÆtÃÅæXIIIöqŦÆĖÖAðēŨé―ßCÁaĮĖæXIIIöqŦÆ`ACAĖoŧĖLģCoŧĖúðĒĩ―D6á5áÅæXIIIöqŦŠášĩÄĒ―DášðĶĩ―5áÉæXIIIöqŧÜð^ĩ―DAM[ŦÁaÉĻŊéæXIIIöqŧÜĖ^Í}ŦúĖÖßĮóC ĮóðüPģđ―ŠCÁaŦtĖđpxÍášģđČĒāĖÆvíę―D
41.iäLvCėûáÁ|CRpūCŠŦņCcqCÃcIqC―ÎFqCRcKG:qgûÉŠåģęéNatural killerŨEÆŠå^IgADüYúãwC29(6), 759-764, 1999.29Š6p.759`p.764 YåņúÉĻŊéûĖÆu@\ÉÂĒÄð·é―ßCûĖŨEŦÆuðSĪčũą
CP
Cp
ĖÆp
ĖTuZbgÉÂĒÄCÜ―ĖtŦÆuðSĪsIgAÉÂĒÄĒĩ―DûÉÍŨEŽŠŠLxÉÜÜęÄĻčCčũą
CP
Cp
ĖÉ―ĐÁ―Dp
ĖTuZbgÅÍNKŨEĖÍTŨEæčČBŨEæč―ĐÁ―DNKŨEÍÉĻĒÄECXīõÉηéĐRÆuðSÁÄĻčCsIgAÍIgAÍŨÛīõÉÎĩÄIv\jÆĩÄąÆŠmįęÄĒéDûÉÍīõhäÉð§ÂÆvíęé\ŠČNKŨEÆsIgAŠÜÜęÄĒéąÆŠmFģęCęûh{ĖLøŦðĶī·éāĖÆvíę―D
42.RcKG :AIDSÆÆuwĖiāD·ė§ÅėåwIv1F79-85C1999P1999.3.(―Ž 11N3)·ė§ÅėåwIv1Š1p.79`p.85.@GalloįŠAIDSģŌĐį human T cell lymphotropic
virus type 3ðŠĢĩÄCAIDSĖaöECXÅ éÆņĩ―D CD4zŦTŨEÅÍCTŨEeaŦHIV-1ÍCXCR4ðC}Nt@[WĻæŅũóŨEÅÍC}Nt@[WeaŦHIV-1ÍCCR5ðŧęžęZv^[ÆĩÄNü·éDCD4zŦTŨEĖTh1ŨE,ĻæŅTh2ŨECA|g[VXCFasČĮĖÆuwĖmĐÍHIVīõĖðÉvĢĩ―DAIDSÆuwÉæčTCgJCCPJCŠtŦÆuÆŨEŦÆuĖoXðÛŋČŠįCĐRÆuÆlūÆuÆŠĶŊÅÆuðēß·é@\ĖaÔðūįĐÉĩ―D
43.ŅvėmCRčqCiäLvCRcKG.@lÉâģĩĒûoPAÉÖ·éĪ.C\WÆÎĖRÛŦĖärÆŧęįĖđpĖÂ\ŦÉÂĒÄDŪėãČåwIv21
43-52C2000C\WK[OÆÎĖRÛŦĖärðĒĩ―DûoāŨÛÉÎĩÄC\WK[OÍŨÛÛĖÉZÔÚGģđéÆÍČEÛøĘŠFßįę―ŠCÎĖęÉÍŨÛÛĖÉÚGĩąŊéąÆŠKvÅ Á―DC\WK[OÍLøZxČšÉóß·éÆEÛøĘÍĩļãĩ―DÎÆC\WK[Oðđp·éÆCC\WK[OãĖPAÉΊLøÅ Á―D
44.iäLvCėûáÁ|C―ÎFqCÃcIqCRpūCŠŦņCcqCRcKG.åņwĖóÔsĀÆûĖÆu\ŽŽŠ.@ŽČÕ°@53(5): 815-820, 2000.@YåņúÉÍóÔsĀŠCgĖIXgXŠFßįę―DYåņ4úĖûĘÍóÔsĀŠÄāĒļXüðĶģČĐÁ―DYåņ4úĖåņwĖóÔsĀŠĒÆCÁtR`][ZxCû}NtA@[WĖŠlÆČéXüðĶĩCûŠå^IgAZxCčũą
Cp
ĖÍálÆČéXüðĶĩ―D
45.RcKG: jĖŧóÆjÛÉηéķĖhä―@\.·ė§ÅėåwIv, 2:67-77 , 2000.@―Ž12N3.@PęĖŨÛīõĮÉæéSīöĖĒEæęĘÍjÅ éDWHOÍjĖSĶCëģĶC`dĖļÆōÜÏŦĖh~ðÚIÆĩCžÚÄšZúŧwÃ@ð\ĩ―DjÛÉÎĩÄĒÆuðĶ·ŨEÍCÅßŧĖķÝŠūįĐÉģę―Natural Killer T(NKT)ŨEÅ Á―DInterferonÁðYķ·éNatural KillerŨEÆInterleukin-4ðYķ·éNKTŨEÍÝÉTCgJCYķð}§ĩÄCjÛÉηéÆuðēßĩÄĒéāĖÆlĶįęéD
46.iäLv, AĢšv, ß{T, ėÎã, RcKG: NîŌÉĻŊéDEXA@ðpĒ―§xÆt[TCgg[ÉæéAčũą
āCaCIZxĖŠč. ·ė§ÅėåwIv, 2:49-54 , 2000.@―Ž12N3.@NîŌðÎÛÆĩÄC§xĻæŅAčũą
āCa2+ZxĖŠčðsÁ―D§xÍjŦÍŦæčāLÓÉĐÁ―DÜ―Ačũą
āCa2+ZxÍCŦŠjŦæčLÓÉĐÁ―DîŌĖAčũą
āCa2+ZxÍCNŽl―ŨEāCa2+ZxĖÍÍÉ čCAčũą
ÍtŨEÆŊlÉ@\ĩĪéąÆŠ@ģę―D
47.iäLvCAĢšvCRcKG.@·ė§ė_šnæĖîŌÉĻŊé§xÆAčũą
āCaCIZxDú{_šãwïG@49(2), 98-104,
2000@―Ž12N7.@·ė§ėnæĖNîŌðÎÛÆĩÄC§xĻæŅAčũą
āCa2+ZxĖŠčðsÁ―D§xÍjŦÍŦæčāLÓÉĐÁ―DÜ―Ačũą
āCa2+ZxÍCŦŠjŦæčLÓÉĐÁ―D§xŠļĩÄĒéęÉÍAčũą
āCa2+ZxŠÁĩÄĻčCAčũą
āCa2+ZxðŠč·éąÆÉæčVlŦeé ĮĖaÔðūÉvĢ·éāĖÆvíę―D
48.RcKG: CtGUīõĮÆÆu―.·ė§ÅėåwIv, 3:87-96 , 2001.@―Ž13N4.CtGUīõÉηéķĖÆu―ððāĩCCtGUīõĮÉĻŊéffCĄÃC\hÚíĖiāðTāĩ―DCtGUīõÉηéÆuÍŨEáQŦTŨEĖUąÆŠå^IgARĖÉæéSÆuŠåĖÆČÁÄĒéDCtGUÉæé]E]ĮÉæéSðhŪ―ßÉÍC\hÚíŠdvÅ éDCtGUÉæé]E]ĮĖpxŠAXsČĮĖÁčĖōÜĖgpÉæčÁ·éÂ\ŦðĶī·éņŠ éDßNCtGUĖvŽffŠsíęéæĪÉČčCÜ―CtGUĖĄÃÉRECXÜŠgpÂ\ÆČÁ―Dŧ_ÅÍCtGUīõÉdĮÆČéąÆŠ\zģęéCÆuóÔĖášĩÄĒéûcÆîŌÖĖ\hÚíŠøĘIÅ ëĪD
49.ž_āŊüCūcģCcFCRcKG.·ė§ssĖÅėŧęÉĻŊépęĖKvŦÉÖ·éēļ·ė§ÅėåwIv, 3:51-56 , 2001.@―Ž13N4. ŲÆņĮĖņŌŠ,@ĄÜÅÉCOlģŌĖÅėCÜ―ÍCÎðĩ―oąðŋ,@Ü―,@ŧĖÉ,@ģŌĖķŧIwiðméKvŦðīķ鯯āÉCR~
jP[VsŦðīķÄĒ―.@ņŌŠßépęĖxÍ,@æļKvČĖÍCúípïbCŧĩÄÅėÉKvČpïbÆĒĪąÆÅ čCŧĖæĪČ\ÍĖ éi[XĖįŽŠßįęÄĒéDÅėģįÛöĖpęģįÉĻĒÄÍCpęðėgĩČŠįÕ°ÅôÅŦéi[XĖįŽðæčŧ·éKvŠ éÆlĶįęé.
50.RcKG:1.
BĪ_ķðÜÆßéDi[VOEgDfC2002(7),
30-31.
51.RcKG:2.b·
CĪ\ð·é. i[VOEgDfC2002(7), 42-43.
52.
Nagai N, Hayashi Y and Yamada S. A flow cytometric analysis for evaluation of
human salivary neutrophils. Asahikawa Medical College Research Buletin 1(12):36-40,
2003 ŪėãČåwĪtH[
53. RcKG.@āÂŦēß@\áQĖ éģŌĖÅė. Ė·ēß@\ĻæŅĖ·ēß@\áQĖðDNjJX^fB25(1):4-10,
2004. ÂŦ·xæčāĒĖ·ðÛĩÄĒéqgÍC37ÅøĶĮGlM[YķðĩÄĒéDĩĐĩĘÆĩÄĖ·ēßĖPíŦŠÛÄČĒąÆŠķļéDąĖÆŦ_ogDâĐRÆuEKÆuðSĪÆuSŨEÍ―ĩCPíŦĖÛĖ―ßÉĖ·ēßĖZbg|CgðÏĶCTCgJCðYķðsĪDąĖÆŦPíŦŠÛÅŦČŊęÎCãâĮðcĩ―čCS·éąÆŠ éDPíŦðlūĩ―qgĖsČĘÅ éÆālĶįęéŠC_onâÆunĖiŧÉæÁÄūįęéLČĘĖŲĪŠ―ĒDaÔððĩ―KØČÎÉæčsČĘð·éąÆŠÂ\ÆČéD
54. RcKGC{cqqFÄz@\D§ð·éĖÍķŦÄĒéĐįūD
NjJX^fB25(4):277-280, 2004
55. RcKGC{cqqFzÂ@\DĖāðétÆpD
NjJX^fB25(5):356-360, 2004
56. RcKGC{cqqFðEš@\DOOSbNĖåØČŦD
NjJX^fB25(7):548-552, 2004
57. RcKGC{cqqFÁŧEzû@\DķŦéāÆðÂéÍ―įŦD
NjJX^fB25(8):628-632, 2004
58. RcKGC{cqqFĖ@\DJWČĖÍĖĖŦ
NjJX^fB25(9):708-712, 2004
59. RcKGC{cqqFãÓ@\DÃÝÄÍĒŊČĒĖÍD
NjJX^fB25(10):788-792, 2004
60. RcKGC{cqqFāŠå@\DČĒĘÅåŦČÍD
NjJX^fB25(11):868-872, 2004
61. RcKGC{cqqFĖtēß@\DlÔŠąĐįŅČĒíŊD
NjJX^fB25(13):1061-1065, 2004
62. RcKGC{cqqFĖ·ēß@\DĖ·ĖjSÆÍD
NjJX^fB25(14):1143-1146, 2004
63. RcKGC{cqqFķĖhä@\DLŊÍēQDĖĖK[h}D
NjJX^fB26(1):36-40, 2005
64. RcKGC{cqqFīo@\DOîņðLb`·éAei.
NjJX^fB26(2):116-120, 2005
65. RcKGC{cqqF^Ū@\Dļ§ÉÂįę―lĖĖņHD
NjJX^fB26(3):196-200, 2005
66. ß{TCJ{―ėqCrcIqCâčNq. âaFCėÎãCŽŅüqCcšģ}CiäLvCėâríCRcKGCðävüqCcCĄ_Ã}CxāüaC{cqqCäqÄTqCėû: îŌĖwXv[VŪÆĩÄĖ
^ŪĖLpŦDÅėĖ_ĐįĖl@DR~
jeBPA7(1), 58-61, 2005
67.
ûŠ\
1.RcKGCīqCâäšFCęōÛVF įØĖPcá. æTPņú{ŽČwïbMnûï@PXVVNT.
2. RcKGCīqCâäšFCęōÛVCüRã^vCnÓņCÁĄēi :cAHÎĖQĮá. æTQņú{ŽČwïbMnûï PXVVNPP.
3. RcKGCËcNCcęCcįq@{ėKšCŽ{R~CÔHūY :Ž@Null
cell ALL ĖÆuwICd°IĒ. æSPņú{twïï PXVX NS.Ž}Ŧpč
ŦaALLÅÍsurface
markerðLĩČĒNull
cell ALLŠßžðĩßCŧĖÁŦĖðūŠŌ―ęÄĒéDNull cell ALLĖaĖČĐÉÍģíp
Ėin vitroRĖYķð}§ĩ―čĩÄsuppressor@TŨEĖŦiðÛLĩÄĒ―čCd°IÉeĘŽEĖŠärIĮBĩCVĢ{][ŠLxÅ|][`ŽŠžÅ éČĮCÆuwICd°IÉT ĻæŅBp
ĖŦóðęLĩÄĒéāĖŠ éąÆŠĪĐŠĶ―D
4. RcKGC―ŅLęCâg ļCRč@LCŽręCōŋC{ėKšCŽ{R~CÔHūY : Ž
ALL ĖeíÆu\ĖĒ.@ÁÉ T cell ALL ÉĻŊéđúËüÆËĖeŋÉÂĒÄ. æWRņú{ŽČwïï@PXWONT.Ãs.Ž}Ŧpč
ŦALLÉĻŊéŧwÃ@CúËüÃ@ŠīÆuOulCx^į―C―
C―p
CTŨECBŨE, D
CD
ĻæŅP
V\CaŨEŠin
vitroRĖYķÉĻæÚ·eŋČĮÉÂŦĒĩ―DT cell ALLÉĻŊéđúËüÆËÉæédÄČ@\ášÍFßįęČĐÁ―D
5. RcKGC{ėKš : wZWcAÅĐģę― IgA tĮĖĄÃÆoß.@æTVņú{ŽČwïbMnûï PXWONU.
6. RcKGC{ėKš :@ŽE}`MÆáNŦÖßE}`ĖÅßĖĄÃÆÆuwIĒ. æTWņMãwï@PXWONPO.
7. RcKGC{ėKš : ŽĖE}`MĻæŅáNŦÖßE}`ÉĻŊéÆuwIĒÆÅßĖĄÃ. æTWņú{ŽČwïbMnûï@PXWONPO.
8. RcKGCâgļCãīĮYC{ėKšCŽ{R~CÔHūY :
qgp
ŠŧRīÆĩÄĖ
Asialo GM1 zŦŨEĖðÍ. æPOņú{Æuwï@PXWONPQ.F{s.
Asialo GM1RīÍNl―ÅÍAŦÅ Á―ŠCŽ}Ŧpč
ŦaĖnull cell^Ėč
ĖęÍzŦÅ Á―D
9. RcKG : ŽnĖðÍ@|@gXtF@|. æTXņú{ŽČwïbMnûï@PXWPNU.
10. RcKG: Epstein-Barr EBXīõĮ. æUOņú{ŽČwïbMnûï PXWPNPP.
11. RcKGC{ėKšCŽ{R~CÔHūY : RORshRĖðpĒ―qgNatural Killer ŨEŦĖŧÉÖ·éðÍ. æPPņú{Æuwï@PXWPNPQ.qgnatural killer(NK)ŨEīóŦWIŨEĖŨE\ĘŋðĒĩ―DK562WIŨEÍasialo GM1, asialo GM2,
globoside,paragloboside, ForssmanðLĩÄĒ―DRasialo GM1RĖCRglobosideRĖuÉæčŨEáQŦÍášĩ―DNKŨEÍasialo
GM1CglobosideðWIŨE\ĒÆĩÄFŊĩÄĒ―D
12. RcKGC{ėKšCŽ{R~CÔHūY: Ž}Ŧpč
Ŧa°ðúÉĻŊé@Natural
Killer ŨEŦĖĒ. æQSņú{Õ°twïï@PXWQNPO.o_s. Natural killer(NK)ŨEÍCRîáėpëL·ép
Å éDŽ}Ŧpč
Ŧa°ðúÉĻŊéNKŨEŦÍášĩÄĒ―DInterferon, interleukin 2Éηé―ŦāášĩÄĒ―DP
ĖNKŨEŦÉ^ĶéeŋÍFßįęČĐÁ―D
13. RcKGC{ėKšCŽ{R~CÔHūY : qgNatural Killer ŨEĖ―lŦ
ÉÖ·éðÍ. æPQņú{ÆuwïPXWQNPP.åäs.PercollsAą§xųzS@ÉæčqgNKŨEðZkĩ―DqgNKŨEÍáädÅ č`ÔwIÉå`ĖčũąðÁ―p
ĖZkģę―ŠæÉķÝĩ―DąĖŠæÉÍrÔ
Æ[bgņ`ŽĖāĖÆ[bg`ŽĖāĖÆŠķÝĩ―DqgNKŨEÍInterferon,
interleukin 2É―ĩ―DP
ÉÍNKŨEŦÍFßįęČĐÁ―D
14. RcKGC{ėKšCŽ{R~CÔHūY :@Ž}Ŧpč
ŦaÉĻŊé Natural
Killer ŨEŦáš@ĖðÍ.@æSTņú{twïï@PXWRNS._Ës.Ž}Ŧpč
ŦaÉĻŊénatural
killerŨEŦÍášĩÄĻčCinterferon, interleukin 2ð^ĩÄāNlxÜÅņĩČĐÁ―D
15. RcKGC{ėKšCŽ{R~CÔHūY :@Ž}ŦaÉĻŊé@Natural@Killer ŨEŦáš@ĖĒ.æPPņú{Õ°ÆuwïïCPXWRNU.@ss.Ž}Ŧpč
ŦaÉĻŊénatural
killerŨEŦáš@ÆĩÄaŨEĐgĖÖ^ÍĶīģęČĐÁ―ŠCīĖeŋŠūįĐÆČÁ―D
16.
Yamada, S., Miyagawa, Y., Komiyama, A. and Akabane, T. : Natural killer@cells in childhood acute
lymphoblastic leukemia. 5 th International Congress of Immunology. August,
1983. ss. Ž}Ŧpč
Ŧa°ðúÉĻŊénatural
killerŨEŦÍášĩÄĒ―D Interferon, interleukin 2Éηé―ŦāášĩÄĒ―D
17.
Yamada, S., Komiyama, A. and Akabane, T. : Natural killer cell activity in
long-term survivors of childhood acute lymphoblastic leukemia. 17 th
International Congress of Pediatrics. November, 1983.11. (1983N11). Manila, Philippine. Ž}Ŧpč
Ŧa°ðúÉĻŊénatural
killerŨEŦÍášĩÄĒ―D Interferon, interleukin 2Éηé―ŦāášĩÄĒ―DLeu 7zŦŨEÍĄÃÍášĩÄĒ―ŠCĄÃIđãÍģíŧĩ―DALLģÉĻŊéNKŨEĖŋIČãŠĶīģę―D
18. RcKGC{ėKšCŽ{R~CÔHūY: Ž}Ŧpč
ŦaÉĻŊé\hIŠWúËüÆËĖNatural
Killer ŨEÉ^ĶéeŋĖĒæQTņú{Õ°twïï@PXWRNPO..Ž}Ŧpč
ŦaÉĻŊé\hIŠWúËüÆËĖnatural
killerŨEÉηé}§øĘÍFßįęČĐÁ―DIn viroÉĻŊéúËüÆËÉæÁÄNKŨEŦĖŠFßįę―D
19.―ŅLęC RcKGC{ėKšCŽ{R~CÔHūY:ŽaÉĻŊéNatural Killer ŨEÉÖ·éĒ.@æ86ņú{ŽČwïï@PXWRNPO.åã
20.öōõFCRcKGC{ėKšCŽ{R~CÔHūY:ŽaÉĻŊéÚAãĖNKŨEÄ\zÉÖ·éĒ. æ86ņú{ŽČwïï@PXWRNPO.åã
21.
Yamada, S., Ruscetti, F., Overton, R., Talmadge, J., Herberman, R. and@Ortaldo, J. : Regulation of
human NK cells by IL-2. 17 the International Leukocyte Culture Conference.
August, 1985. New York, USA.Natural killerŦðSĪqgåčũąp
(large granular lymphocyte, LGL)ĖK562ÉηéŨEáQŦÍinterleukin 2(IL 2)ÉËķĩ―DIL 2ÍVNLGLÉ]ĘxÅIL 2Zv^[ðUąĩCLGLĖBðĢiģđCŨEáQŦðģđ―DIL 2ÍÃ~LGLĖBðUąĩCÍČŨEáQŦðL·éLGLĖBðÛ·éĖÉKvĐÂ\ŠÅ Á―D
22.Ortaldo
J, Yamada, S., Kovacs L, Peppolini S, Young H and Ruscetti, F.Interleukin-2
regulation of human natural killer cells. Analysis of molecular acivation
events. Federation of American Societies for Experimental Biology.1986.4. PXW6N4St.Louis, USA. VNqgåčũąp
(large granular lymphocyte,
LGL)Íinterleukin
2(IL 2)Zv^[ĻæŅmRNAðÛLĩÄĒČÁĐ―ŠCIL 2ÍIL 2Zv^[ĻæŅmRNAðUąĩ―DÜ―fos éĒÍc-mycŠņâ`qŠUąģę―D
23.Reynolds
CW, Young H, , Yamada, S., Ortaldo J :T cell receptor gene rearrangement and
mRNA expression in human and rat LGL. Fed.Proc.@1986.8. Hawaii, USA. PXW6N8qg éĒÍbgĖåčũąp
(large
granular lymphocyte, LGL)Í@\IČTŨEĀ―ĖmRNAðŧĩÄĒČĐÁ―DNKŨEÍTŨERīZv^[ðWIŨEĖFŊÉgpĩÄĒČĒąÆðĶĩÄĒ―D
24. RcKGCsėģîCÔŠNFCöōõFCėC{ėKšCŽ{R~CÔHūY : Ž
ALL ÉĻŊéLGL ĻæŅTŨEĖ IL 2@ receptor UąÉÖ·éĪ. æSXņú{twïï@PXWVNS.Ž}ŦpŦa(ALL)ģÉĻĒÄinterleukin 2(IL 2)|{åčũąp
(LGL)ĖŨE1Â―čĖIL 2@ receptor(IL 2R, CD25)ÍášĩÄĒČĐÁ―DIL 2|{LGLĖŨE1Â―čĖeaŦIL 2RÍģíÅ čCąęįŨEĖeaŦZv^[eaŦÍášĩÄĒ―DIL 2ÆIL
2RĖs\ŠČÝėpŠąęįŨEĖŨEáQŦĖášĖęöÆČÁÄĒ―D
25. RcKG : íŠ`õŦPjĮðCZŠ`õŦPjĮlĮóðæĩ―Zí. æVPņú{ŽČwïbMnûï. PXWVNU.
26. RcKGCŽ{R~CÔHūY: Ž ALL ÉĻŊéIL 2 Uą LGL ĻæŅT ŨEĖŨEáQŦÉÖ·éĪ. æTOņú{twïï PXWWNS.ĄÃĖŽ}ŦpŦa(ALL)ģÉĻŊéVN éĒÍinterleukin 2(IL 2)|{åčũąps
(LGL)ĖŨEáQŦøĶÍášĩÄĒ―ŠCLGLĖ\ÍášĩÄĒČĐÁ―DLGLĖŨEáQŦ\ÍCĄÃĖALLģÉĻĒÄ\ĖášÅÍČCãĖŨEáQßöÉĻŊé@\ášÉæčIðIÉášĩÄĒ―D
27. RcKG: Åßoąĩ―nŦA―
ÛīõĮÉÂĒÄ. æVRņú{ŽČwïbMnûï PXWWNU.
28. RcKGCŽ{R~CÔHūY: Ž ALL ÉĻŊé Natural Killer ŨEsubset ĖðÍ.@æROņú{Õ°twïï@PXWWNPP.CD16,
CD45RAÍnatural
killer(NK)ŨEÉĻĒÄŦŧVOið^ĶÄĒéDŽ}ŦpŦa(ALL)ģÉĻĒÄCD16(Leu 11), CD45RA(2H4)zŦŨEŠášĩÄĒ―D
29. RcKG : Åßoąĩ―JsoN^[ݰÉÂĒÄ.@æVSņú{ŽČwïbMnûï PXWWNPQ.
30.RcKGCöōõFCŽ{R~CÔHūY@:
CD45R(2H4)+ Natural killerŨEĖðÍ -Ž
ALLÉĻŊéŧĖŪÔ.@æTPņú{twïï@PXWXNS.CD16,
CD45RAÍnatural
killer(NK)ŨEÉĻĒÄŦŧVOið^ĶÄĒéDŽ}ŦpŦa(ALL)ģÉĻĒÄCD16(Leu 11), CD45RA(2H4)zŦŨEŠášĩÄĻčnatural killer cytotoxic factor(NKCF)YķŠášĩÄĒ―DALLģÉĻŊéNKŨEŦášĖęöÆĩÄNKCFYķĖᚊčģę―D
31.RcKG : r^~j^ÉæéVķr^~jRŦoĮĖ\h.@æVTņú{ŽČwïbMnûï PXWXNT.ž{s
32.RcKG : nŦA―
Û, ĐFuhE
ÛČĮĖīõĮÉĻŊéRķĻŋī
óŦÉÖ·éĒ.@æVUņú{ŽČwïbMnûï
PXWXNPP.
33.RcKGCŅ`O: r^~j^ÉæéÁŦVķr^~jRŦoĮĖ\h.@æPPņ·ėsãwï PXWXNPQ.·ės
34.RcKG : Åßoąĩ― MRSA īõĮ. æVVņú{ŽČwïbMnûï 1990NU. åŽs
35.RcKG : ä`oĖFßįę―VķÉηér^~jĖ^.@ æVWņú{Ž@@@ ČwïbMnûï PXXONPP.ž{s
36.RcKG: šĖŦŽlĮÉĻŊ鎷zgpĖNîĖ]ŋ@ĖĒ. æVXņú{ŽČwïbMnûï PXXPNU. ž{s
37.RcKG : Åßoąĩ― ]ĖÕ°IÏ@. æWOņú{ŽČwïbMnûï PXXPNPP. b{s
38.ÔšCŅĀa]CėCĢļCRcKG: 12ÎÉÝįę―}ŦóŦpßĖ1áDæW1ņú{ŽČwïbMnûï PXX2N6 7ú.Éßs
39.ŅĀa]CÔšCėCĢļCRcKG, žörF: oŲÔAÉÝįę―ņÆuŦ
Ų
îDæW2ņú{ŽČwïbMnûïPXX2N111ú. ž{s
40.ŅĀa]CÔšCėCĢļCRcKGCžörFCĄžī: oŲÔAĖóÉÝįę―ņÆuŦŲ
îDæ47§a@Ã{ãwïDPXX2N1112ú.åãs
41.ėCĢļCRcKG: oÃŽh{{sÉđĩ―tF`ĮĖŽ·ÉηéeŋÉÂĒÄDæ96ņú{ŽČwïï PXX3N423ú. Ąls
42.RcKG, ėCĢļ, Ôš, ŅĀa} : Transient stem cell proliferation,
Megakaryo-oriented lineage ðđĩ―_EĮóQĖPá. æSW§a@Ã{ãwï PXXRN930ú.Dys
43.RcKGFŽAM[ŦÁaÉĻŊétÃÅæXIIIöqŦÆÁaŦtÆĖÖA.@MBVF[CwmbzÁaĪïPXX4N610ú.ž{s
44.AĢšvCiäLvCRcKG: ÅėwķĖ―ßĖŧwĀą(1)ŨEĖ`ÔÉĻæÚ·Z§ģĖeŋÆyfŦÖĖpHE·xĖeŋðð·é―ßĖtŋðpĒéĀąDú{ŧwïæ72tGNï@1997N330úC. (―ŽXN3)ú{ŧwïG72Šp.35.ÅėwķĖ―ßĖŧwĀąe[}ÆĩÄCķĖâãÃÉÖWĖ[ĒtÞŋðpĒéû@ðHvĩ―DEEáĢntÅĖÔ
`Ô˰ũūÏ@ÆS@ðpĒ―nmFąĐįZ§ģŧÛððģđéĀąčðlÄĩ―DÜ―tĖJ^[[ŦĖKpHŠ7.4CĖ·Š36.5ÉÛ―ęÄĒéRðlĶģđéÞŋÆĩ―D
45.AĢšvCiäLvCRcKG: ÅėwķĖ―ßĖŧwĀą(2). pHŠčÆŧęðpĩ―ŧwvŠÉšĪîbÛčĖwK. ú{ŧwïæ73HGNïC1997N 926úCâč. (―ŽXN9)ú{ŧwïG73Šp.186.ÅėwŠðĩÄĻŨŦŧwĖmŊÉCpHŠ éDŧĖŠčÉĖæĪČvŠÉšĪîbÛčĖwKÛöðąüĩ―D1.NffČĮÉČÖ@ÆĩÄąŠLpĒįęÄĒéDŧąÅąÉæépHŠčðÜļsĒC[^ÉæéĘÆĖáĒðlĶģđCLøÉÂĒÄĖðð}Á―D2.ļ§Č[^ðgp·éęÅāCģmČlðūéÉÍC@íĖģĩĒæčĩĒ(Zģ)ŠsÂČąÆðoąģđ―D3.ÅėŠėÅĖvwĖmŊŠdģęÄĒéąÆðlķĩC―ÏlCηCë·ðģĩßģđCļxCģmģĖTOððģđ―D
46.iäLvCėÎãCß{TCRcKG: _šnæÉĻŊéîŌĖÆëÅĖðÆåÏIKīDú{NČwwïæ13ņåïC
1997N1119ú CDPRŠ4.p.219-220.@ (―ŽXN11)·ė§ėnæĖîŌÉĻŊéîŌĖÆëÅĖðÆåÏIKīÉÂĒÄĒĩ―DîŌĖÆëÉĻŊéðĖKÍÍCŦÆNîÉæÁÄŲČéąÆŠūįĐÆČčCÜ―KÍÆĀîÆĖļęĖöxŠåÏIQOLlÆÖW·éąÆŠĶīģę―D
47.RcKGCėû^|CÃcIqC―ÎFqC iäLvDqgęûÉÜÜęéNatural@killerŨEDú{NČwwïæ14ņåïDP4Š4p.252-253.1998N1017úCD(―ŽXN10)ęûCÁÉûÉÍŨEŦŠŠLxÉÜÜęÄĒ―D―ĖÆäŨCęûÉÍP
Š―Cčũą
ÍČĐÁ―Dp
ĖÉÍÏŧÍĐįęČĐÁ―ŠCp
ĖTuZbgÅÍNKŨEĖŠ―ĐÁ―DęûĖNKŨEÍÉηéĐRÆuðSÁÄĻčCīõhäÉð§ÁÄĒéÆvíę―D
48.ėû^|CiäLv CÃcIqC―ÎFqC
RcKGDęûIgAÆęeĖXgXÆĖÖAŦDú{NČwwïæ14ņåï1998N1017úC. (―Ž10N10) ú{NČwwïGP4Š4p.250-251.ęûŠÆuĘÅDęÄĒéąÆÍæmįęÄĒéŠCęûð^ĶéąÆÍęeÉÆÁÄėŅÅ éÆŊÉgĖICSIXgXðšĪDąĖæĪČęeĖXgXÍęûĖIgAŠåĘČĮÉeŋ·éÆlĶįę―DęeĖXgXCöûóĩCęûPAÆęûIgAŠåÆĖÖAÉÂŦĒĩ―D
49.iäLvCAĢšvCėÎãCß{TCyŪuÛĒC RcKGD·ė§ėnæĖîŌÉĻŊé§xÆAčũą
āCaCIZxĖÖADú{NČwwïæ14ņåï@1998N1016úCD(―Ž10N10)P4Š4p.186-187.@·ė§ėnæĖîŌÉĻŊé§xÆAčũą
āCaCIZxðŠčĩ―Dčũą
āCaCIZxÍssĖŲĪŠ_šæčĒXüŠ čCŦŠjŦæčāĐÁ―D§xŠļĩÄĒéęÍAčũą
āCaCIZxŠåĩÄĻčCAčũą
āCaCIZxĖŠčÍVlŦeé ĮĖaÔðūÉð§ÂāĖÆvíę―D
50.AĢšvCiäLvC RcKGCėÎãCŽŅüqCėâríCyŪuÛĒD·ė§ė_šnæÉĻŊéîŌĖAJVEZxƧxNîäĻæŅķðÆĖ@ÖWDú{NČwwïæ14ņåï@1998N1016úC. (―Ž10N10)P4Š4p.188-189.@·ė§ė_šnæÉĻŊéîŌĖAJVEZxƧxNîäĻæŅķðÆĖÖWðĒĩ―D_šnæÉĻŊé§xNîäÍC_š^ŦîŌÅÍss^ŦîŌæčĒXüðĶĩ―DcĻÅĖdŠā―į·^ŪâúõÔĖáĒÆĒĪķïâķóĩĖ―fÆ@ģę―Dss^næÅͧxNîäŠáCAJVEZxÍĒXüðĶĩ―D
51.iäLvCRpūCŠŦņCcMCRcKG:qgVķi`
L[ŨEĖŦŧÆrglN`Zv^[Ėŧ. ú{_|ŧwï1999Nåï1999N331ú CŠ. ú{_|ŧwï73ŠÕ§p.193. (―Ž11N3)CD2/CD2RŠqhÉæčCVķTŨEĻæŅNKŨEÉĻĒÄŦŧRīCD25ÆCD69ĖŧððÍĩ―DCD25ÆCD69ĖŧÍŽlæčāáCÜ―ŨEáQŦÉĻĒÄāŊlĖXüŠÝįę―DVķTŨEĻæŅNKŨEĖCD2ŠqhÉæéŦŧÉĻĒÄCÆuŠ}§ģęÄĒéąÆŠĶīģę―DÜ―VķNKŨEĖCD2ŠqhÉæčCVNRŋĀ3ĖūČŧŠÝįę―D
52.RcKGCiäLvCėûáÁ|C―ÎFq.qgûĖÆu\ŽŽŠÆåņwĖsĀóÔ.@ú{NČwwïæ15ņåï.1999N1113úžÃŪ@ú{NČwwïG15Š4Cp759-764.Yåņ4úÉÍûÍC334ml/úöxCsIgAÍ204mg/úöxŠåģęÄĻčCûŨEÍ1678Â/mm3(čũą
62C}Nt@[W31Cp
6)öxÅ Á―DóÔsĀÆûŽŠÆĖÖWÍCóÔsĀŠĒÆCsIgACčũą
Cp
ČĮĖÆu\ŽŽŠŠálðĶ·XüŠÝįę―Dû}Nt@[WĖÍ―}Nt@[WĖæčāCÜ―sĀŠÜéÆlðĶĩ―D
53.iäLvCėÎãC―ęJūCß{TCAĢšvCRcKGCyŪuÛĒD·ė§ė_šnæĖîŌĖNÆúíķÉÖ·éĒDîŌĖåÏIKxķ@\Dú{NČwwïæ15ņåï@1999N1113úCžÃŪ15/4C234-235.@·ė§ė_šnæĖîŌ2626lÉAP[gēļðsÁ―DåÏIKīĖĘSÅÍĖbCSŪhĖŠčlŠĮDČXüÉ Á―D§xÍŦĖęÍŠčlŠCwWlðãņÁÄĒ―DåÏIKīĖĘSÅÍĐgĖĖēāĮĒÆĐoģęÄĒéąÆŠmFģę―D
54.AĢšvCÉĄŋæC―CžīÞÛüCâōqqCRčįGCiäLvCRcKG.@A}es[pļûx_[ĖbNXøĘÉÂĒÄF]gEģĐįĖØDú{NČwwï@æ15ņåï1999N1113úžÃŪ15Š4C226-227. A}es[pļûx_[ĖbNXøĘÉÂĒÄ]gEģĐįĖØðsÁ―DDÝĖčÍŋgÜLĶðÁģđbNXøĘðĶĩ―ŠCĒČčÍŋgÜLĶðļģđéXüŠ Á―DDÝĖčÍģðš~ģđbNXøĘðĶĩ―ŠCĒČčÍģðãļģđéXüŠ Á―D
54.RcKGCiäLvCß{TCėÎãCcšģ}CJ{―ėqCrcIqCâaFCėâríCŽŅüqCÐR}CâčNqCAĢšvDgbh~Éæé^ŪŨŠnatural killerETŨEÆunÉ^ĶéøĘDú{NČwwïG2000N1116(4),364 , 2000.·ė§ÅėåwĖwķðÎÛÆĩCgbh~ÉæéBRUCE^ŪŨvgRÉæč^ŪxðÝčĩCnatural
killerETŨEÆunÉ^ĶéøĘðFACScanðpĒÄnatural killerETŨEÆunŨEðC DelfiaðpĒ[sE@ÉÄnatural killerŨEŦðŧęžęŠčĩ―D Natural killerETŨEÆunĖŦŧŠFßįę―D
55.iäLvCß{TCėÎãCcšģ}CJ{―ėqCrcIqCâaFCėâríCŽŅüqCÐR}CâčNqCAĢšv
CRcKG. šā·
v[ÅĖ^ŪŠ]gÉ^ĶéøĘDú{NČwwïG2000N1116(4),363 , 2000@^ŪÉæÁÄ]gÉÏŧŠNąéĖĐĮĪĐÉÂĒÄŋgĖTOĻæŅŋŅæĖgĖTOðpĒÄCšā·
v[ÅĖ
jĖOãĖ]gðŠčĩ―DÎÛÍNČwķ6žÅCNîÍ18ÎĐį20ÎÅ Á―DãŠÉĻŊéŋgĖwaxing and
waningČĮĖoŧĘÉĻĒÄCąÔCdĘČĮĖķE·ŠFßįęéĐĒĩ―D3žÉĻĒÄÍ^ŪãCķĪæčEĪĖŋgŠĮoŧĩ―D1žÉĻĒÄÍ^ŪOãÆāŋgÍķĪŠEĪæčĮoŧĩÄĒ―D2ž ÉĻĒÄÍ^ŪOãĖ·ÍFßįęČĐÁ―D^ŪãĖŋgĖÜLĶĻæŅp[XyNgÏŠlÉĻĒÄCŧęžęÁXüŠĶīģę―ęŠÏ@ģę―D
56.AĢšvCiäLvCRcKGCėÎãCŽŅüqCėâríCrcuÛĒ. ·ė§ė_šnæÉĻŊéîŌ˧xNîäÆAJVEZxĻæŅķðEķKĩÆĖÖW(ŧĖ2).
ú{NČwwïG16Š4p.335C2000.·ė§ė_šnæÉĻŊéîŌ˧xNîäÆAJVEZxĻæŅķðEķKĩÆĖÖWðĒĩ―D
57.RcKGCiäLvCß{TCėÎãCcšģ}CJ{―ėqCrcIqCâaFCėâríCŽŅüqCâčNq.gbh~ÉæéęßŦĖÅå^ŪŠnatural killerŨEĻæŅnatural killer T ŨEÉ^ĶéøĘ. ú{NČwwïG2001N1017(4),246, 2001·ė§ÅėåwĖwķðÎÛÆĩCgbh~ÉæéBRUCE^ŪŨvgRÉæč^ŪxðÝčĩCnatural
killer(NK)ŨEĻæŅnatural
killer T (NKT)ŨEÉ^ĶéøĘðFACScanðpĒÄðÍĩ―D^ŪŨÉæčCNKŨEÍÁĩ―ŠCNKTŨEÍÁĩČĐÁ―Dú{NČwwï2001N10āōs
58.iäLvCß{TCJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCcšģ}CėâríCRcKG.
^ŪðpĒ―îŌĖ―ßĖwXEv[Vú{NČwwïG2001N10.17(4),245, 2001@ú{NČwwï2001N10āōsD·ė§îŠsĖ65ÎČãĖîŌðÎÛÆĩÄC
^ŪðpĒ―wXEv[VÉÖ·éĒðsÁ―D{ĪÍîŌÉKĩ―
^ŪvOðJĩCŧęðpąĀ{·éąÆÉæčCîŌĖsŪĖÍášh~C\õÍĖŧCQuality of life (QOL) üãÉĮĖæĪÉņ^·éĐðl@·éąÆðÚIÆĩÄĒéD―Ž12N4Đį―Ž13N3ÜÅC2ņCv24ņĖ
^ŪuĀðĀ{ĩC^ŪOãĖģŠčCN3ņĖrxŠčCQOLÉÖ·éAP[gēļČĮĖĘĐįĒðsÁ―D
59.ß{TCJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCcšģ}CiäLvCėâríCRcKGëd
^ŪðpĒ―îŌwXv[VÉÖ·éĪDæ60ņú{öOqķwïC2001. 11. 2, ėD
60.iäLvCJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCcšģ}CėâríCRcKGCß{Tëd
^ŪðpĒ―îŌĖwXv[VÉÖ·éĪD―Ž13NxNÃčĪ\ïC2002. 2. 18, ·ė§Ąi·ėsjD
61.Sachihiro
Yamada, Nobuo Nagai, Toshiya Nosaka, Shigeyo Okuno,@ Takiko Amemiya, Noriko Ikeda, Masae Tamura, Kazuhiko
Iwatsuki,Yoshiko Kobayashi,@ Iwasaki Akiko and Yutaka Nasu.@æ29ņÛtwï2002N824-28úC\EEffect of transient
maximum exercises by treadmill on natural killer cells and natural killer T
cells in adult healthy human peripheral blood. 29th World Congress of the
International Society of Hematology International Journal of Hematology
76(Supplement I ) 134, 2002.The percentages and absolute count of NK cells as
well as NK activity were increase after the transient maximum exercises in
human peripheral blood, however, NKT cells were not observed even after the
exercises.
62.Nobuo
Nagai, Yutaka Nasu, Takiko Amemiya, Noriko Ikeda, Akiko Iwasaki, Kazuhiko
Iwatsuki, Shigeyo Okuno, Yoshiko Kobayashi, Masae Tamura,Toshiya Nosaka,
Sachihiro Yamada. Interaction between activation and expression of vitronectin receptor
in human cord blood NK cells.@29th World Congress of the International Society of Hematology.International
Journal of Hematology 76(Supplement I ) 44, 2002.æ29ņÛtwï2002N824-28úC\EAlthough the percentages
of CB-NK cells expressing CD25 and CD69 were decreased, however, the
cytotoxicic activities of CB-NK cells were similarly activated to adult NK
cells by cross-linking with CD2. The expression of VNRŋvĀ3 was possibly suggested the
associated with the cytotoxicic activities in CB-NK cells.@
63.RcKGCiäLvCß{TCėÎãCJ{―ėqCrcIqCâaFCcšģ}CėâríCŽŅüqCâčNq.@îŌÉĻŊéšā·
v[ÅĖ^ŪŠ]gÉ^ĶéøĘ.æ18ņú{NČwwï2002N1019úCÂÎs.ú{NČwwïG18(4),339, 2002.îŌÉĻŊéšā·
v[ÅĖ1ÔĖ
^ŪÉæčŋgÍãŠūŊÅÍČCLÍÍÉE]DĘÉoŧĩ―DŋgŠoŧÉRĩĒĘÉāUąģę―ąÆÍC^ŪĖøĘÆĩÄNZ[VøĘÆÆāÉC]ĖŦŧŠĻąéąÆŠūįĐÆČÁ―D
64.iäLvCß{TCJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCcšģ}CėâríCRcKG.@
^ŪðpĒ―îŌĖ―ßĖwXv[V(2)æ18ņú{NČwwï2002N1019úCÂÎs. ú{NČwwïG18(4),344, 2002îŌðÎÛÆĩ―čúIČ
^ŪĖpąÉæéCgĖ@\ĻæŅSĘÉĻæÚ·øĘÉÂĒÄĒĩ―DrxgĖ@\ÉĻĒÄÍLÓČüPÍÝįęČĐÁ―ŠCÛģęéXüŠFßįę―DÜ―C
^ŪÉQÁ·éąÆÉæéĐMCÓ~ŠZtEGtBJV[ū_ðÁģđ―āĖÆvíę―D
65.ß{TCiäLvCcšģ}CJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCėâríCRcKG:
^ŪðpĒ―îŌwXv[VÉÖ·éĪi2jDæ61ņ ú{öOqķwïC2002. 10.23-25CģĒ―ÜsD
66.iäLvCJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCcšģ}CėâríCRcKGCß{Tëd
^ŪðpĒ―îŌĖwXv[VÉÖ·éĪ(2)C―Ž14NxNÃčĪ\ïC2003.3.11, ·ė§Ąi·ėsjD
67.ß{TCiäLvCcšģ}CJ{―ėqCrcIqCâčNqCâaFCŽŅüqCėâríCRcKGCėÎã:
^ŪðpĒ―îŌwXv[VÉÖ·éĪi3jCæ62ņ ú{öOqķwïC2003.10.23Css.
68.RcKGCiäLvCėâríCß{TCėÎãCJ{―ėqCrcIqCâaFCcšģ}CŽŅüqCâčNq.@^ŪxÝčÉæéL_f^ŪĖLøŦÆĀSŦÉÖ·éĒ.æ19ņú{NČwwïåï2003. 10.25-26CssD19(4):291, 2003Nq2ž(22ÎÆ21Î)ðÎÛÆĩCgbh~Éæč^ŪxðÝčĩCãÓĘ( metabolic
equivalents, METS), SšŦúOûkiventricular premature contraction, VPCjĖŧp^[ČĮððÍĩCLøŦÆĀSŦÉÖ·éĒðsČÁ―D·CŦėÆčl(ventilation
threshold, VT)ðwWÆĩCVTÜÅ^Ūxðã°éąÆðÚWÆĩ―EH[LOÍĀSĐÂøĘIČL_f^ŪÅ éąÆŠĶīģę―.@Ü―L_f^Ū\ÍĖĒlÍSŠČĒ―ßCVTSĖčÉÍNîCŦĘĐįß―Åå_fÛæĘÉæéL_f^Ū\Íðlķĩ, L_f^Ū\ÍŠĒlÍ70%HRmaxöxCáĒlÍ80%HRmaxöxðÚĀÉĩ―ûŠĮĒÆĶīģę―.
69.iäLvCß{TCJ{―ėqCrcIqCâčNqCâaFCėÎãCŽŅüqCcšģ}CėâríCRcKG.@
^ŪðpĒ―îŌĖwXv[V(3).æ19ņú{NČwwïåï2003. 10.25-26CssD19(4):292, 2003.
@næîŌĖwXv[VÉÖ·éēļĪĖęÂÆĩÄCwāĖšā·
v[ðpĩ―
^ŪuĀð―Ž12NxĐįpąĩÄĒéDŧĖãĖoßðÜßÄ
^ŪJnãŧęžę1NÜ―Í3Nðoßĩ―NXĖrxĖgĖ@\CåÏIKīCZtEGtBJV[ĖÏŧÉÂĒÄärĒĩ―DîŌðÎÛÆĩ―čúIČ
^ŪĖpąÉæéCgĖ@\ĻæŅSĘÉĻæÚ·øĘÉÂĒÄĒĩ―DrxgĖ@\ÉĻĒÄĖĨäļ~ĖĘÉĻĒÄÍüPģę―ŠCžÉĻĒÄÍÛģęéXüŠFßįę―D
70.AĢšvCiäLvCRcKG.@]gŠčÉæéļûĖDÝÆA}es[øĘĖÖWÉÂĒÄĖĒ.ú{NČwwï@æ19ņåï2003.
10.25-26CssD19(4):290,
2003
71. iäLvCrcIqCJ{―ėqCâčNqCâaFCėÎãCŽŅüqCcšģ}CėâríCRcKGCß{Tëd.
^ŪðpĒ―îŌĖwXv[VÉÖ·éĪ(3) 2004N (―Ž16N) 26ú.―Ž15NxNÃčĪĒ_ï.·ė§·ėÛ
3NÔpąĩ―NXÉÂĒÄģĻæŅSĖoßÉÂĒÄĒĩ―ŠC
^ŪĖúÔðĘĩÄåŦČÏŧÍFßįęČĐÁ―BÜ―C3NÚĐįÍęCjŽðæčüę―^ŪðĩÄĻčCąĖęÉÍ^ŪãĖģãļCSĖÁŠFßįę―B
72.
Sachihiro Yamada, Tomoko Honda. EFFECT OF AEROBIC AND ANAEROBIC EXERCISES ON
NATURAL KILLER CELLS IN HEALTHY ADULT HUMAN PERIPHERAL BLOOD.12 th.
International Congress of Immunology.Montreal, Canada, July18-24, 2004@ We have investigated the effect of aerobic
walking exercises and anaerobic exercises by treadmill on NK cells in healthy
adult human peripheral blood. NK activities after the aerobic and anaerobic
exercises were generally increased via the increase of the absolute numbers of
LGL and CD3-CD16+56+NK cells in healthy adult human peripheral blood.
NŽl―ÉĻĒÄCEH[LOÉæéL_f^ŪÆgbh~Éæéģ_fŦ^ŪŠi`
L[ŨEÉ^ĶéøĘÉÂĒÄĒĩ―DL_f^ŪÆģ_fŦ^ŪãÉÍNŽl―ÉĻŊéCD16+56+i`
L[ŨEĖÁÉæčCi`
L[ŨEŦÍÁĩ―D
73. AĢšvAÔōĀÞAāxėüAã@bAiĢGAŽāä]CÁĄÜčAšcRĒAräFqAŠėüaAâVĄüARcKG
A}Zs[øĘĖØĀąĐįĐ―ļûĖIŅûEgĒû
2005N (―Ž17N) 215ú.―Ž16NxNÃčĪĒ_ï. §Ąu°
74.
Sachihiro Yamada, Tomoko Honda: EFFECT OF AEROBIC AND ANAEROBIC EXERCISES ON
NATURAL KILLER CELL NUMBERS AND ACTIVITIES IN HEALTHY ADULT HUMAN PERIPHERAL
BLOOD. 30 th World Congress of International Society of Hematology, Istanbul,
Turkey, September 28 –October 2,
2005
RcKGA{cqqFNŽl―ÉĻŊéi`
L[ŨEÆŦÉηéL_f^ŪÆģ_f^ŪĖøĘAæ30ņÛtwïÅ\C2005N928ú-102úgRACX^u[
75.xāüa@kĒēÆ@âčNq@ėÎãAðävüq@c@cšģ}@ËcRüq@ėârí@Ą_Ã}@Ąīq@{cqq@äqÄTq@RcKG@âaF@ß{TAiäLv@ėûF
^ŪðpĒ―îŌwXv[VÉÖ·éĪiSj
·ė§NÃčĪĒ_ï2006@― Ž 1 7 N x N à čĪ Ē _ ï
― Ž 1 8 N 2 1 0 ·ė§Ąu°
76.ICOH
2006 Congress Fiera Milano Congressi, Milan (Italy)@ June 11-16, 2006 THE STUDY OF THE HEALTH-PROMOTION PRACTICE FOR
AGED@PEOPLE USING
WATER EXERCISE : Yutaka Nasu CNobuo Nagai ,Miwa Horiuchi Shigeyo Okuno ,Masae Tamura ,Shizue
Fujigaki, Sachihiro Yamada,Toshiya Nosaka ,Tomoko Honda ,Akiko Iwasaki ,Yuko
Mikoshiba,Kazuhiko Iwatsuki
@
Īņ
1.ėÎãC―ęJšCß{TCAĢšvCRcKGCcšģ}CÎėÝŋqCŽŅüqCėâríCyŪuÛĒCiäLvCīĀÞF―Ž7`8Nx·ė§ÅėåwÁĘĪïâāĪŽĘņCîŌĖNÆúíķÉÖ·éĪDŠS·MS125ÅC ―Ž9Ni1997Nj6s.îŌŠNÉÂĒÄĮĖæĪÉlĶCķĖČĐÅĮĖæĪÉNðÛĩC߿ίĩÄĒéĖĐČĮCîŌÂXĖÓŊâúíķSĘðIÉcŽĩCģįÉNÓŊâÛsŪÆķINxÆĖÖWÉÂĒÄāūįĐÉ·éąÆðÚIÆĩÄĪðsÁ―DÔņÆĩÄWv\ĖfÚāsÁ―D
2. ėÎãC―ęJšCß{TCAĢšvCRcKGCcšģ}CÎėÝŋqCŽŅüqCėâríCyŪuÛĒCiäLvCīĀÞF―Ž7`10Nx·ė§ÅėåwÁĘĪïâāĪŽĘņC(―Ž11N3)îŌĖNÆúíķÉÖ·éĪDŠS·MS250ÅCæIIIÍ. §xÆAčũą
āCaCIZxĖÖADP140-147C·ė§ė_šnæĖîŌÉĻŊé§xÆAčũą
āCaCIZxðŠčĩ―Dčũą
āCaCIZxÍssĖŲĪŠ_šæčĒXüŠ čCŦŠjŦæčāĐÁ―D§xŠļĩÄĒéęÍAčũą
āCaCIZxŠåĩÄĒ―D§xĀŠlÍjŦŠCŦæčCÜ―_šÍssæčĐÁ―ąÆÍ§xĖļÍPTHĖÖ^ÉæčAĖCaŠÁĩCAŨEŠŦŧģęéąÆÉæččũą
āCaCIZxŠÁĩ―āĖÆ@ģę―D/æIVÍ. §xNîäÆAJVEZxĻæŅķðEķKĩÆĖÖW[sXÆ_šĖnæ·É
Úĩ―Ē[p148-162C·ė§ė_šnæÉĻŊéîŌĖAJVEZxƧxNîäĻæŅķðÆĖÖWðĒĩ―D_šnæÉĻŊé§xNîäÍC_š^ŦîŌÅÍss^ŦîŌæčĒXüðĶĩ―DcĻÅĖdŠā―į·^ŪâúõÔĖáĒÆĒĪķïâķóĩĖ―fÆ@ģę―Dss^næÅͧxNîäŠáCAJVEZxÍĒXüðĶĩ―D§xNîäĖģÍ_ėÆCÆëāJCāsCX|[cČĮĖgĖŪðâKĩŠeŋĩÄĒ―D/ŠS·MS250ÅC ―Ž11Ni1999Nj9s. /ŠS·M.îŌĖNÆúíķÉÖ·éēļP759-764:65ÎČãĖ2626lĖAP[gēļĖĘðÜÆß―.AP[gāeÍîŌĖNâčÉÂĒÄĖĀÔēļCîŌĖNâčÆÐïICĐRIvöĖÖAĒCîŌŠnæÅNÉķÅŦé―ßĖ^ŪâķÉÖ·éÎôÉÂĒÄCÅėĖ_ĐįĖĒÅ Á―D
3.ėûáÁ|CÕãxüCRcKGCiäLvC―ÎFqCÃcIq.―Ž8`10Nx·ė§ÅåwÁĘĪâāĪŽĘņDęûh{ÉÖ·éÅėîüfĖėŽDæ3Í.qgûÉŠåģęéNatural@killerŨEÆŠå^IgADp36-52, ŠS·MS65ÅC―Ž11Ni1999Nj4s.@NKŨEÍÉĻĒÄÍECXīõÉηéĐRÆuðSÁÄĻčCsIgAÍŨÛīõÉÎĩÄIv\jÆĩÄąÆŠmįęÄĒéDęûCÁÉûÉÍŨEŽŠŠLxÉÜÜęÄĒ―D―ĖÆäŨCęûÉÍP
Š―Cčũą
ÍČĐÁ―Dp
ĖÉÍÏŧÍÝįęČĐÁ―ŠCp
ĖTuZbgÅÍNKŨEĖŠ―ĐÁ―DęûÉÍīõhäÉð§ÂÆvíęé\ŠČNKŨEÆsIgAŠÜÜęÄĒéąÆŠmFģęCęûh{ĖLøŦðĶī·éāĖÆvíę―D
4.ž_āŊüCcFCRcKGCūcģ.·ė§ssĖÅėŧęÉĻŊépęĖKvŦÉÖ·éēļ. ―Ž11Nx-―Ž12Nx·ė§ÅėåwÁĘĪïâāĪŽĘņ.―Ž13N3
5. RcKGCūcģC*oHōRüqCŠqđqC^|Ūįiïv―Ž14N(2002N)331úÅėåwÉĻŊétBWJAZXgģįvOĖJÉÖ·éĪ.ĪúÔ@―Ž11N41ú~―Ž14N331ú(3NÔ).―Ž13N41ú~―Ž14N331ú. 3NÔÉí―čCÅėåwÉĻŊétBWJAZXgģįvOÉÂĒÄĪðsÁ―D―Ž11NxÉĻĒÄðUķwĖmŊðtBWJAZXgÉð§Äéû@ÆĩÄErbĖĖæÉŪæģęé@\ŦVGđĖŪæÍ
ÓŠŨĩÄÅŦČĐÁ―DÜ―
ßĖâčÉÖĩÄÍCģŌ˧ęÉ―ÂC éĒÍaÔķĖmŊÉîÃÆĖ§ęÉ―ÁÄĀ{·éąÆðÝæĪÆĩÄāÅŦČĐÁ―D―Ž12NxÉĻĒÄđķæņ]ÔÉĻŊé@\ŦĖæņSđĖÄzŦŠôðŪæ·éąÆðÝ―DĩĐĩCæęSđCæņSđŠČšŪæģęéĖĐÉÂĒÄC éĒÍÃŽŌŽÉÂĒÄĖ\ŠČmŊŠČĒÆðŠïĩĐÁ―D
ßĖâčÉÖĩÄÍCpW}
ÓÅsĪąÆðÝ―D
―Ž13NxÉĻĒÄwķÉÆÁÄKpxCaÔķĖmŊÉîÃĒ―ZpŠCūÅŦŧĪČÚð °ÄĀKĩ―DæęSđCæņSđĖðÉÖĩÄÍCeûkúCeoÉúÉÂĒÄĖ\ŠČmŊŠKvÅ čCģįÉÃŽŌŽÉÂĒÄĖ\ŠČmŊŠKvÅ Á―DĄņĖĪÉæčCÅėåwÉĻŊétBWJAZXgģįvOĖJŠęŪŽĩ―æĪÉvĪDtBWJAZXgĖCūÉÍðUķwCaÔķwĖmŊŠK{Å éąÆCpW}
ßÅĀKŠÂ\Å éąÆCĀįę―ÔÅĖtBWJAZXgĖCūÉÍSđCxđĖŪæC ĖGfČĮĖî{IČZpðSÆĩÄCū·éąÆŠKvÅ éąÆČĮŠūįĐÉČÁ―D
6.RcKGCcšģ}C^|_q. iäL―Ž15N(2003N)331ú.·ė§ÅėåwÉĻŊéaÔķģįvOĖĒÅĖ1NÔ[―ŽPQNx]ÍĮó}lWgģįvOÉÂĒÄĖĪðsČĒCŧĖãĖ2NÔ[―ŽP3Nx`―ŽP4Nx]ÍĮóðð·é―ßĖîbImŊÅ éaÔķģįvOÉÂĒÄĖĪðsČÁ―D―Ž10NjxĖWhiteæķĖC―Ž11NxĖPetriniæķĖCÜ――Ž12NxĖArmstrongæķĖu`Ėģöû@ĻæŅu`āeðĒĩ―DĮó}lWgģįvOÉÂĒÄĖĪÉĻĒÄCu1.Įó}lWgÉKvČmŊÍÅėģįĖúÉwK·éąÆŠÅŦéD2.Įó}lWgðĀH·éąÆÉæčÅėĖ{ŋÉÂĒÄð·é·éąÆŠÅŦéD3.Įó}lWgðsĪÆCģŌÉŋĖĒPAŠÅŦCÜ―CÅėtCėÆÃ@mC4.\[V[J[Ch{mČĮ įäéEíĖlŅÆÆĖĶÍŠÅŦéD5.ú{ÉĻĒÄāĮó}lWgÍwxðÜßÄ įäéxÅwÔąÆŠÂ\Å éD 6.ú{ĖķŧÉ Á―Įó}lWgû@ðpĒéÆĮĒDĩĐĩCĀÄCÄCĮĒāĖÍģĒĖÅCĮó}lWgĖÁŦðð·éKvŠ éDvČĮŠūįĐÆČÁ―DÅėåwÉĻŊéaÔķģįvOðm§·é―ßÉC―Ž13NxÉÍŌüķÉηéaÔķĖÁĘu`ÆAP[gēļĒC1.āäŌ@aÔķI. ĮóŌ@Öé·oÅÆ2k{Ō@aÔķwII (ÄzCzÂCĖtEdðŋoXCtCÆu)@ú{ÅėĶïoÅïðgp·é௯ĩ―DÄzCzÂCĖtEdðŋoXÍaÔķĖjðČĩCÜ―tCÆuÉÖ·éaÔķÍÄzCzÂCĖtEdðŋoXĖaÔķðð·éĖÉîbÆČéĐįÅ éD
5.ß{TiĪã\ŌjCėÎãCėâríCiäLvCcšģ}CJ{―ėqCrcIqCâaFCRcKGCŽŅüqCâčNqFNÉηéwXv[VŪÆĩÄĖ
^ŪĖLpŦĖĒD―Ž14~16NxČwĪïâā ĪŽĘņ@―Ž17N3iîÕĪiCj(2)jĪŽĘņC2005D
ŧĖž
1. RcKG: lĖĖ\ĒÆ@\\zâč@i[bVOJbW@2004(12):22
2. RcKG: ĀKÉð§ÂðU}\ i[bVOJbW
t^8y[W@2005(4)
3. T§ĒČ@NÆ·õ 2005N4
4. T§ĒČ@5ADAY^Ū2005N5
5. T§ĒČ@2ADAY^Ū2005N6
6. T§ĒČ@MĮ 2005N7
7. T§ĒČ@ģĩĒģĖŠčû2005N8
8. T§ĒČ@Aa 2005N9
9. T§ĒČ@L_f^ŪĖøĘ 2005N10
10. T§ĒČ@CtGU 2005N11
11. T§ĒČ@][Į 2005N12
12. T§ĒČ@HĻAM[ 2006N1
13. T§ĒČ@ÔēĮ 2006N1
Funded
Study ĪŽ
1. ėÎãC―ęJšCß{TCAĢšvCRcKGCcšģ}CÎėÝŋqCŽŅüqCėâríCyŪuÛĒCiäLvCīĀÞ. ―Ž7`10Nx·ė§ÅėåwÁĘĪïâāCFîŧÐïÉÖ·éIĪ|·ė§ĖîŧĻæŅîŌĖNâčĖÎôÆŧĖ]ŋ|
2. ėûáÁ|CÕãxüCRcKGCiäLvC―ÎFqCÃcIq.―Ž8`10Nx·ė§ÅåwÁĘĪâāCęûh{ÉÖ·éÅėîüfĖėŽ
3. RcKGCūcģCoHāVRüqCŠq đqC^| ŪįD―Ž11`13Nx·ė§ÅėåwÁĘĪïâāCÅėåwÉĻŊétBWJAZXgģįvOĖJ.ĪúÔ@―Ž11N41ú~―Ž14N331ú(3NÔ).*―Ž13N41ú~―Ž14N331ú
4. ß{TCėÎãCkī}CJ{―ėqCrcIqCâčNqCRcKGCiäLv. ėâríCcšģ}CâaFCŽŅüq.―Ž11`14Nx·ė§ÅėåwÁĘĪïâāC·ė§ÅėåwÁĘĪ
^ŪðpĒ―îŌĖwXEv[VDÅėîüÉæéQOLĖĒD
5. RcKG(Īã\Ō)Ccšģ}CĄĢ_q. iäLv―Ž12`14Nx·ė§ÅėåwÁĘĪïâāC·ė§ÅėåwÉĻŊéaÔķģįvOĖĒD ·ė§ÅėåwÁĘĪ―Ž12Nx-―Ž14NxâāD―ūĩC―Ž12NxÍu·ė§ÅėåwÉĻŊéĮó}lWgģįvOĖĒ.vÆĩÄsÁ―D―Ž12N41úĐį―Ž13N331úÜÅ.―Ž13N41úĐį―Ž15N331úÜÅ
6. ß{TiĪã\ŌjCėÎãCėâríCiäLvCcšģ}CJ{―ėqCrcIqCâaFCRcKGCŽŅüqCâčNqFNÉηéwXv[VŪÆĩÄĖ
^ŪĖLpŦĖĒD―Ž14~16NxČwĪïâā
7. kĒēÆCâaFCRcKGAxāüaC{cqq. }bT[WĖčĘĪ@―Ž1U~18Nx·ė§ÅėåwÁĘĪïâā
8.IRCŌWã\2004.3.31Žžbüq(ÓCŌ)A―ęJšAAnita FisherA]ĄTVAcãĒ]AOcũCAcFAācëãARcKGAČöĮ]: ·ė§ÅėåwŲķŧÅėj
[Y^[AMar 2004.
9. RcKGiĪã\ŌjA{cqqDL_f^ŪĖĐRÆuÉηéøĘÆĀSŦÉÖ·éĒD
17~19Nx·ė§ÅėåwÁĘĪïâā
10. âaFiĪã\ŌjCėÎãCcšģ}Cß{TCRcKGCkĒēÆCėâríCâčNqCxāüaDķKĩaðL·éîŌĖwXv[VŪÆĩÄĖ
^ŪĖLøŦĖĒ. ―Ž17~19NxČwĪïâā
―Ž17N@190~@―Ž18@90~@―Ž19@80~
11. ―Ž17Nx@ÅėĀHÛĪZ^[@ÅėnævĢĪå
^ŪvWFNg@ß{TAâčNqAâaFAėÎãAðävüqAcAcšģ}AËcRüqAėâríAĄ_Ã}AxāüaA{cqqAäqÄTqAkĒēÆARcKG
12. ß{TiĪã\ŌjCėÎãCėâríCiäLvCcšģ}CJ{―ėqCrcIqCâaFCRcKGCŽŅüqCâčNqFNÉηéwXv[VŪÆĩÄĖ
^ŪĖLpŦĖĒD―Ž14~16NxČwĪïâā Īņ@―Ž17N3
13.―Ž17Nx·ė§ÅėåwĪWï
RcKG@L_f^ŪĖĐRÆuÉηéøĘÆĀSŦÉÖ·éĒ
ß{TARcKG@
^ŪðpĒ―îŌĖwXv[VÉÖ·éĪ
kīēÆARcKGD}bT[WĖčĘ]ŋÉÖ·éĒ
―Ž17N39ú
öIŪ
1.RcKG.―Ž9Nx.·ė§Vl{ÝÆAŋ@ÅėwĪCïutCīõĮCtGUCzKs1997N(―Ž11N)929ú
2.RcKG.―Ž11Nx.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž11N1027úCž{sCÅėZ^[ČŠĖ
3.RcKG.·ė§ÅėåwöJuĀ@―Ž13N(2001N)74ú.110ÎÜÅNÉķŦéé.fUCi[Ct/īĖķ.@qgÍÎðÆé(Áî)ÆÆāÉCVŧŠNąÁÄéąÆŠmįęÄĻčÜ·ŠCÅåõ―(120Î)ÜÅCNÉķŦé―ßÉÍCÂlĖwÍ(fUCi[Ct)ŠKvÅ éąÆŠūįĐÆČÁÄŦÜĩ―Dķ―ðÛĩÄĒ―ßÉÍCīõĮâā(Šņ)ÉÎĩÄgĖðįéKvŠ čÜ·DĄņÍCxÉÆunðBģđÄŦ―qgŠC110ÎÜÅNÉķŦééÉÂĒÄCl@ĩÄÝÜĩ―DlÞĖiŧÍqgÆunĖBÆ[ĒÖWŠ čÜ·DīõĮâāÉÎĩÄíĪÆunÍCŊÉĐŠĐMð·úÉķķģđÄĒîÕÆČÁÄĻčÜ·D
4.RcKG.―Ž13N(2001N)927ú19:00-21F00.ÉßsžtßöŊŲåÃuAyģšvÉÄuoRÆ·õvÉÂŦu
5.RcKG.―Ž13N(2001N)930ú.ú{Ô\ÐĢÆÉĶÍ(̧ŋïĒ)
6.RcKG.―Ž13Nx·ė§ÅėĶïĪCïutCtBWJAZXgC―Ž13N1024-25úCž{sCÅėZ^[ČŠĖ
7.RcKG.―Ž13N(2001N)129ú13:00-15F00.JAãÉßčĮxķïuï@h{Æ·õÉÂŦu
8.RcKG.šaÉėa@tBWJAZXguKïC―Ž14N628-29úCšaÉėa@CîŠs
9.RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž14N1011-12úCž{sCÅėZ^[ČŠĖ
10.RcKG.―Ž14N1025ú9:00-11F00.îŠsîŌNuAï/NÃčģš.~ÉüĐÁÄĖßēĩûÆyĖ.OaXNu30ž
11.RcKG.―Ž14N1025ú15:00-15F30.xmĐŽ.îŌNu/NÃčģš.]|\h
12.RcKG.MBåwtBWJAZXgĪCïutC―Ž14N119úCž{sCMBåwãwtŪa@
13.RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž14N1115úCž{sCÅėZ^[ČŠĖ
14.RcKG.MBåwtBWJAZXgĪCïutC―Ž14N1130úCž{sCMBåwãwtŪa@
15.RcKG.šaÉėa@tBWJAZXguKïC―Ž15N82úCšaÉėa@CîŠs
16.RcKG.§§{âa@tBWJAZXguKïC―Ž15N823úC9F00-17F00§§{âa@C{âs
17.RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž15N109ú10F00-16F00C40žCž{sCÅėZ^[ČŠĖ
18.RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž15N1016úCž{sCÅėZ^[ČŠĖ
19.RcKG.MBåwtBWJAZXgĪCïutC―Ž15N118úCž{sCMBåwãwtŪa@
20.RcKG.MBåwtBWJAZXgĪCïutC―Ž15N1122úCž{sCMBåwãwtŪa@
21.RcKG.―Ž15N1218ú10:00-11F30âÜŅą.îŠsîŌNuAï/NÃčģš.~ÉüŊÄĖîŌĖNĮÆyĖ.ŽlæîŌNu{Vï55ž
22.RcKG.ÉėKâÅėXe[VĪCïtBWJAZXgĪCïutC―Ž16N229úC·ė§ÅėåwCîŠs
23. RcKG@·ė§îŌAï@fCT[rXZ^[EõĪCïutCĻĐâZ^[u{ÝÉĻŊéīõĮÆ\hÉÂĒÄv―Ž16N(2004N)315ú10F20-15F30
23.1Žžbüq(ÓCŌ)A―ęJšAAnita FisherA]ĄTVAcãĒ]AOcũCA
cFAācëãARcKGAČöĮ]: ·ė§ÅėåwŲķŧÅėj
[Y^[ Mar 2004.
24.RcKG@―Ž16N(2004N)65úC613ú ŅcsÐïĶcïĪCïCÎJŌZ^[65ú, ģuöŊŲ613úuMRSAÛÛŌĖfCT[rXZ^[ēpÉÂĒÄv
25.RcKG.šaÉėa@tBWJAZXguKïC―Ž16N84úCšaÉėa@CîŠs
26.RcKG.§§{âa@tBWJAZXguKïC―Ž16N87úC9F30-16F30§§{âa@C{âs
27.RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž16N1021ú10F00-16F00C40žCž{sCÅėZ^[ČŠĖ
28. RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž16N1022ú10F00-16F00C40žCž{sCÅėZ^[ČŠĖ
29. RcKG.OlfD―Ž16N1212ú10F00-17F00ŲķŧÅėÛĪå, Éßa@
30. RcKG. ―Ž17NxîŠskęæÂŦüŧAg·
31. RcKG@îŌNu@îŌĖĖÆNÉÂĒÄu@ōĶcC14F00-15F00―Ž17N(2005N)422ú@30l
@
32RcKG.§§{âa@tBWJAZXguKïC―Ž17N(2005N)730úC9F30-16F30§§{âa@C{âs@
32. RcKG.tBWJAZXguKïC―Ž17N(2005N)822ú, ―Ž17N1028ú10F00-16F00C40žCÉßa@CÉßs
33. RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž17N(2005N)922-23ú10F00-16F00C40žCž{sCÅėZ^[ČŠĖ
34. RcKG.Olf@ŲķŧÅėÛĪå,―Ž17N(2005N)1218ú@Éßa@
35.RcKGGfUCi[Ct100Î
@@šaÉėa@NZ~i[―Ž18N(2006N)727úAšaÉėa@
36RcKGGŠņãÕÅėĖî{ðwÔAÕ°wąŌĪCïutC
·ė§ÅėĶï·ė§ÅėģįĪï
@ž{sC,―Ž18N(2006N)728úÅėZ^[ČŠĖ
37RcKG.·ė§ÅėģįĪïCÕ°wąŌĪCïutCtBWJAZXgC―Ž18N(2006N)84-5ú10F00-16F00C40žCž{sCÅėZ^[ČŠĖ
38RcKGFqĖNÆaC
{cš@qįÄw―Ž18N(2006N)95ú{cšŊïŲ
39RcKGFÄzítBWJAZXg
šaÉėa@ÅėĪCï@―Ž18N(2006N)925ú
40DRcKGF@ķKĩaĖ\hÆĄÃ100ÎÜÅĖNķ
―Ž18N(2006N)1023úFîPŠsÐïĶcïFîPŠsÓę ĒZ^[
41RcKGF100ÎÜÅĖNķF―Ž18N(2006N)1024úk1æ·õïAk1æ·õ
41-1RcKGFķKĩaĖ\hFöŊŲ{cwF18N(2006N)126úA{cšŊïŲ
41-2RcKGFîėŌĖÂĮĒA―Ž18N(2006N)1212úANÛF
îPŠsð@ÛÛAšaÉėa@ïcš
42RcKGF^{bNVh[F]ēÄ\huĀF
îPŠsð@―Ž18N(2006N)1215úÛÛîPŠsÓę ĒZ^[
NĮ@·ė§sŽšÞEŌAŋ@―Ž19N(2007N)529ú@ACpĒČņ
Aaģš―Ž19N(2007N)65ú
43.―Ž19NxÛwąõîbĪC[NÃčnæ[_[îbuĀ]
ģĖJjYĄÃðwÔ―Ž19N(2007N)65úîŠsėĄÉ
44.îŌĖNĮ―Ž19N(2007N)921úîŠCIYNuîŠsĪHïŲ
i
ú{Ô\Ð
ãĀS@~õ,―Ž12N317ú`―Ž15N317ú,æ23-1007-362